Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
APOA2,Apolipoprotein A-II,Lifestyle factors,X1050.Time spend outdoors in summer,40093,0.0225120068760169,0.0193079216680695,-0.0153315195933993,0.060355533345433,0.243642948544265
APOA2,Apolipoprotein A-II,Lifestyle factors,X1060.Time spent outdoors in winter,34981,0.0158616875716113,0.02175694087839,-0.0267819165500331,0.0585052916932558,0.465981869933153
APOA2,Apolipoprotein A-II,Physical activities,X1070.Time spent watching television (TV),42189,0.0701076497659932,0.0194149815566341,0.0320542859149903,0.108161013616996,0.000305363091449199
APOA2,Apolipoprotein A-II,Physical activities,X1080.Time spent using computer,34955,-0.0782585358322471,0.019743457593101,-0.116955712714725,-0.039561358949769,7.39218138696553e-05
APOA2,Apolipoprotein A-II,Physical activities,X1090.Time spent driving,30372,-0.107214162609343,0.0217151999539502,-0.149775954519086,-0.064652370699601,7.96369392645237e-07
APOA2,Apolipoprotein A-II,Lifestyle factors,X1160.Sleep duration,44426,-0.032443882671802,0.0176673832148111,-0.0670719537728317,0.00218418842922771,0.066309381133436
APOA2,Apolipoprotein A-II,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,14481,-0.00953184673597849,0.0132356357229542,-0.0354736927529688,0.0164099992810118,0.471434806675699
APOA2,Apolipoprotein A-II,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,14481,-0.0128715939448853,0.0128870488309117,-0.0381302096534723,0.0123870217637016,0.317907931476596
APOA2,Apolipoprotein A-II,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,14481,0.0173735848147442,0.0146962989983432,-0.0114311612220084,0.0461783308514967,0.237156036153752
APOA2,Apolipoprotein A-II,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,14481,0.0279075226965051,0.0150486617963856,-0.00158785442441075,0.0574028998174209,0.063690089947782
APOA2,Apolipoprotein A-II,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,14481,0.00520278375542925,0.0152870011517438,-0.0247597385019885,0.0351653060128471,0.733605154068869
APOA2,Apolipoprotein A-II,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,14481,0.0104062858530093,0.0326107854775963,-0.0535108536830795,0.0743234253890981,0.749651007578438
APOA2,Apolipoprotein A-II,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,14481,0.0126549897844145,0.0330807980393829,-0.052183374372776,0.0774933539416051,0.702060627145613
APOA2,Apolipoprotein A-II,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,14481,0.0323324909491879,0.0233054895103652,-0.0133462684911279,0.0780112503895036,0.165361402540043
APOA2,Apolipoprotein A-II,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,14481,0.0447224506947135,0.0170926987188462,0.011220761205775,0.078224140183652,0.00889377701542898
APOA2,Apolipoprotein A-II,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,14481,-0.00836731413295573,0.0117000935412638,-0.0312994974738327,0.0145648692079213,0.474528311423794
APOA2,Apolipoprotein A-II,Health and medical history,X120039#18.Location of pain during the past week_Upper back,14481,0.0157145299770754,0.0168901385119827,-0.0173901415064108,0.0488192014605615,0.352181225275834
APOA2,Apolipoprotein A-II,Health and medical history,X120039#19.Location of pain during the past week_Lower back,14481,-0.00269565900700765,0.00946045957318754,-0.0212381597704552,0.0158468417564399,0.775694540577281
APOA2,Apolipoprotein A-II,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,14481,-0.0126725353415092,0.0121451916887542,-0.0364771110514673,0.011132040368449,0.296771271300541
APOA2,Apolipoprotein A-II,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,14481,0.00181038741954584,0.0180710758904856,-0.033608921325806,0.0372296961648977,0.920201624216017
APOA2,Apolipoprotein A-II,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,14481,-0.0156119961907747,0.0168465649670706,-0.0486312635262331,0.0174072711446838,0.354089008200799
APOA2,Apolipoprotein A-II,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,14481,-0.00504960363377182,0.0225581808411647,-0.0492636380824547,0.0391644308149111,0.822878740842104
APOA2,Apolipoprotein A-II,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,14481,0.0181553133459831,0.0216860815027557,-0.0243494063994181,0.0606600330913842,0.402501089864548
APOA2,Apolipoprotein A-II,Health and medical history,X120039#7.Location of pain during the past week_Left hip,14481,-0.0138201491541761,0.0132035104185682,-0.0396990295745699,0.0120587312662177,0.295254234953155
APOA2,Apolipoprotein A-II,Health and medical history,X120039#8.Location of pain during the past week_Right hip,14481,-0.014075694515852,0.0125020404332283,-0.0385796937649794,0.0104283047332755,0.260238472195772
APOA2,Apolipoprotein A-II,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,14481,0.0279555395652508,0.0156181350937347,-0.00265600521846911,0.0585670843489707,0.0734843111580792
APOA2,Apolipoprotein A-II,Health and medical history,X120040.Fatigue severity over the past week,14496,-0.0359560699746979,0.0327814588734338,-0.100207729366628,0.0282955894172323,0.272728852841298
APOA2,Apolipoprotein A-II,Health and medical history,X120041.Waking unrefreshed severity over the past week,14498,-0.00818550822561979,0.0325277819125225,-0.0719399607741638,0.0555689443229242,0.801317747075697
APOA2,Apolipoprotein A-II,Health and medical history,X120042.Cognitive symptoms severity over the past week,14495,-0.0814342134714542,0.035328800537213,-0.150678662524392,-0.0121897644185166,0.0211785402537185
APOA2,Apolipoprotein A-II,Health and medical history,X120098.Mobility problems today,14503,0.0219837144694284,0.0379834805897926,-0.052463907486565,0.0964313364254218,0.562753100870439
APOA2,Apolipoprotein A-II,Health and medical history,X120099.Self-care problems today,14503,0.0771409901138562,0.0580242247272408,-0.0365864903515358,0.190868470579248,0.18371659678346
APOA2,Apolipoprotein A-II,Health and medical history,X120100.Problems doing usual activities,14503,0.0132231477548258,0.0362636793296402,-0.0578536637312689,0.0842999592409205,0.71538630390349
APOA2,Apolipoprotein A-II,Health and medical history,X120101.Pain or discomfort today,14503,0.0584889036574305,0.0326896025638488,-0.00558271736771322,0.122560524682574,0.0736002127511657
APOA2,Apolipoprotein A-II,Health and medical history,X120102.Anxiety or depression today,14503,-0.0206383778669348,0.039596289738737,-0.0982471057548593,0.0569703500209897,0.602221495645755
APOA2,Apolipoprotein A-II,Health and medical history,X120103.Scale to indicate how health is today,14450,-0.000843372556200474,0.00408879410539471,-0.00885740900277411,0.00717066389037316,0.836587314415058
APOA2,Apolipoprotein A-II,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,14463,-0.0429042968816975,0.0400281056707615,-0.12135938399639,0.035550790232995,0.283803387458438
APOA2,Apolipoprotein A-II,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",14440,-0.0216822101135955,0.0411314439896877,-0.102299840333383,0.0589354201061925,0.598101427158748
APOA2,Apolipoprotein A-II,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",14475,0.00470590144933806,0.0326186041517209,-0.0592265626880349,0.0686383655867111,0.885288904170206
APOA2,Apolipoprotein A-II,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,14480,-0.0536587230977261,0.0334294152272438,-0.119180376943124,0.0118629307476717,0.108485938317834
APOA2,Apolipoprotein A-II,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,14482,-0.0470525634228872,0.0429718542870518,-0.131277397825509,0.0371722709797343,0.27355135262599
APOA2,Apolipoprotein A-II,Health and medical history,X120109.Feeling bad about self over the last two weeks,14443,0.00701045149887884,0.0430694379072091,-0.0774056467992511,0.0914265497970088,0.87070109481747
APOA2,Apolipoprotein A-II,Health and medical history,X120110.Trouble concentrating over the last two weeks,14483,-0.0675573469437774,0.0432907169172895,-0.152407152101665,0.01729245821411,0.118651735681137
APOA2,Apolipoprotein A-II,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,14469,0.0576469068895234,0.0629858196299705,-0.0658052995852188,0.181099113364266,0.360082874610223
APOA2,Apolipoprotein A-II,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,14401,-0.00546668443956969,0.086233616050224,-0.174484571898009,0.163551203018869,0.949453732711397
APOA2,Apolipoprotein A-II,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",10065,0.0157733302926756,0.0438891959204328,-0.0702494937113728,0.101796154296724,0.719311039367886
APOA2,Apolipoprotein A-II,Lifestyle factors,X1269.Exposure to tobacco smoke at home,40121,0.025455781164193,0.0420534663640725,-0.0569690129093892,0.107880575237775,0.544970184934982
APOA2,Apolipoprotein A-II,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,37432,0.028968684057428,0.0260098294916681,-0.0220105817462415,0.0799479498610975,0.265389705731959
APOA2,Apolipoprotein A-II,Diet and food preferences,X1289.Cooked vegetable intake,43121,-0.0609423151101349,0.0184751885664214,-0.0971536847003208,-0.0247309455199489,0.000972458597649293
APOA2,Apolipoprotein A-II,Diet and food preferences,X1299.Salad  or  raw vegetable intake,41971,-0.0178600781828002,0.0195227633913056,-0.0561246944297591,0.0204045380641587,0.360284296799071
APOA2,Apolipoprotein A-II,Diet and food preferences,X1309.Fresh fruit intake,43076,-0.0279182736803808,0.0192862697073372,-0.0657193623067616,0.00988281494599999,0.147743926428289
APOA2,Apolipoprotein A-II,Diet and food preferences,X1319.Dried fruit intake,40690,-0.0384268842893494,0.0198426365121867,-0.0773184518532354,0.000464683274536554,0.0528034292379342
APOA2,Apolipoprotein A-II,Health and medical history,X134.Number of self-reported cancers,44810,0.0174717703660418,0.034122120205203,-0.0494075852361561,0.0843511259682398,0.608628002077111
APOA2,Apolipoprotein A-II,Health and medical history,X135.Number of self-reported non-cancer illnesses,44811,0.190902925313715,0.0184695476801013,0.154702611860716,0.227103238766713,5.16258727530886e-25
APOA2,Apolipoprotein A-II,Health and medical history,"X136.Number of operations, self-reported",44811,0.074417534019161,0.0181032501628786,0.038935163699919,0.109899904338403,3.95115812643015e-05
APOA2,Apolipoprotein A-II,Health and medical history,X137.Number of treatments or medications taken,44811,0.258355072606557,0.0180818426798107,0.222914660954128,0.293795484258986,3.28115437523436e-46
APOA2,Apolipoprotein A-II,Diet and food preferences,X1438.Bread intake,43513,-0.012568725713543,0.00252785315390712,-0.0175233178952009,-0.007614133531885,6.64848388776126e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X1458.Cereal intake,42538,-0.126704456228094,0.0182798729263548,-0.162533007163749,-0.0908759052924383,4.22728394437139e-12
APOA2,Apolipoprotein A-II,Diet and food preferences,X1488.Tea intake,43226,0.00832550789556691,0.00241865138053644,0.00358495118971549,0.0130660646014183,0.00057752641321504
APOA2,Apolipoprotein A-II,Diet and food preferences,X1498.Coffee intake,41318,-0.0908538348680739,0.0184455670940963,-0.127007146372503,-0.0547005233636451,8.44649670674316e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X1528.Water intake,41490,0.0815444348264887,0.0186236712211864,0.0450420392329633,0.118046830420014,1.19770702411462e-05
APOA2,Apolipoprotein A-II,Lifestyle factors,X1568.Average weekly red wine intake,30478,-0.0548574911154618,0.0216394486426205,-0.097270810454998,-0.0124441717759257,0.0112474834977812
APOA2,Apolipoprotein A-II,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,30473,0.0411597260848021,0.0222123781189065,-0.00237653502825455,0.0846959871978588,0.063890801572221
APOA2,Apolipoprotein A-II,Lifestyle factors,X1588.Average weekly beer plus cider intake,30555,0.0530481245946564,0.0245189286360363,0.00499102446802525,0.101105224721288,0.0305060161728804
APOA2,Apolipoprotein A-II,Lifestyle factors,X1598.Average weekly spirits intake,30438,0.0581877610375669,0.0237989383689237,0.0115418418344765,0.104833680240657,0.0144919313222762
APOA2,Apolipoprotein A-II,Lifestyle factors,X1608.Average weekly fortified wine intake,30534,0.0276656892319902,0.0393338166051161,-0.0494285913140374,0.104759969778018,0.481839074398811
APOA2,Apolipoprotein A-II,Lifestyle factors,X1737.Childhood sunburn occasions,33627,0.00221464684183472,0.021826584002114,-0.0405654578023088,0.0449947514859782,0.919181490855774
APOA2,Apolipoprotein A-II,Health and medical history,X1807.Father's age at death,33092,-0.00450163341144458,0.00279716712137949,-0.00998408096934839,0.000980814146459221,0.107548397506831
APOA2,Apolipoprotein A-II,Health and medical history,X1845.Mother's age,17014,0.00668766842332848,0.00627779477568184,-0.00561680933700794,0.0189921461836649,0.28676010385121
APOA2,Apolipoprotein A-II,Health and medical history,X1873.Number of full brothers,44005,-0.00122717148884097,0.0177073671323664,-0.0359336110682791,0.0334792680905972,0.944748850622569
APOA2,Apolipoprotein A-II,Health and medical history,X1883.Number of full sisters,44010,-0.00977035562016248,0.017714138192265,-0.0444900664770019,0.024949355236677,0.58125475548847
APOA2,Apolipoprotein A-II,Physical measures,X20015.Sitting height,44461,-0.0226110211772898,0.00317410045976355,-0.0288322580784263,-0.0163897842761532,1.06737308800165e-12
APOA2,Apolipoprotein A-II,Cognitive function,X20016.Fluid intelligence score,14555,-0.00740161480724975,0.0292676512646079,-0.0647662112858813,0.0499629816713818,0.800353666714037
APOA2,Apolipoprotein A-II,Cognitive function,X20018.Prospective memory result,15157,0.0143743873951769,0.0386173798761078,-0.0613156771619945,0.0900644519523482,0.709729903626393
APOA2,Apolipoprotein A-II,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),14355,0.00412245377913799,0.00434992081883139,-0.00440339102577154,0.0126482985840475,0.343294210515075
APOA2,Apolipoprotein A-II,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),14346,-0.00507877936414981,0.00435137727456454,-0.0136074788222963,0.00344992009399667,0.243162779602127
APOA2,Apolipoprotein A-II,Cognitive function,X20023.Mean time to correctly identify matches,44270,0.0102232392271393,0.00255541430526095,0.00521462718882781,0.0152318512654507,6.32796521597097e-05
APOA2,Apolipoprotein A-II,Health and medical history,X20107#1.Illnesses of father_Heart disease,38983,0.00324704671420997,0.00544574664397198,-0.00742661670797511,0.0139207101363951,0.551009204035862
APOA2,Apolipoprotein A-II,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,38228,-0.0167619859375228,0.0119664197885432,-0.0402161687230675,0.00669219684802185,0.161296379632544
APOA2,Apolipoprotein A-II,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,38164,-0.00115362814857636,0.0160363021766416,-0.0325847804147939,0.0302775241176412,0.942651196954521
APOA2,Apolipoprotein A-II,Health and medical history,X20107#12.Illnesses of father_Severe depression,38203,-0.0254207987583568,0.0134134594011208,-0.0517111791845535,0.000869581667839993,0.0580773005351599
APOA2,Apolipoprotein A-II,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,38230,-0.0199508344755376,0.00963264778790346,-0.0388308241398284,-0.00107084481124681,0.0383497690565203
APOA2,Apolipoprotein A-II,Health and medical history,X20107#2.Illnesses of father_Stroke,38509,0.00238916015766106,0.00701790558514409,-0.0113659347892213,0.0161442551045435,0.733528733560623
APOA2,Apolipoprotein A-II,Health and medical history,X20107#3.Illnesses of father_Lung cancer,38419,0.00646893054958911,0.00884873280549546,-0.010874585749182,0.0238124468483602,0.464748625687281
APOA2,Apolipoprotein A-II,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,38236,0.00498498849092959,0.011050019696685,-0.0166730501145731,0.0266430270964323,0.651898865947598
APOA2,Apolipoprotein A-II,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,38504,0.00223613033866666,0.00807531475516019,-0.0135914865814473,0.0180637472587806,0.781851182948086
APOA2,Apolipoprotein A-II,Health and medical history,X20107#8.Illnesses of father_High blood pressure,38613,0.00838560046534336,0.00611291233501057,-0.00359570771127735,0.0203669086419641,0.17013840124726
APOA2,Apolipoprotein A-II,Health and medical history,X20107#9.Illnesses of father_Diabetes,38371,-0.0139647932544193,0.00844275180577196,-0.0305125867937323,0.00258300028489376,0.0981241015711709
APOA2,Apolipoprotein A-II,Health and medical history,X20110#1.Illnesses of mother_Heart disease,40860,-0.00859703103961396,0.00620346021549413,-0.0207558130619825,0.00356175098275454,0.165801965746077
APOA2,Apolipoprotein A-II,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,40611,0.00964780824629069,0.00894480867412896,-0.00788401675500207,0.0271796332475835,0.280775600419816
APOA2,Apolipoprotein A-II,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,40484,-0.0134228680941695,0.0196733650485406,-0.0519826635893091,0.02513692740097,0.49506181835438
APOA2,Apolipoprotein A-II,Health and medical history,X20110#12.Illnesses of mother_Severe depression,40548,0.00377103279485362,0.0100200726426745,-0.0158683095847883,0.0234103751744956,0.706660280341395
APOA2,Apolipoprotein A-II,Health and medical history,X20110#2.Illnesses of mother_Stroke,40753,0.00568424603495738,0.00708540169113467,-0.00820314127966657,0.0195716333495813,0.422414464622117
APOA2,Apolipoprotein A-II,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,40571,0.0123420148629684,0.0125281907729217,-0.0122132390519582,0.0368972687778951,0.32456145877035
APOA2,Apolipoprotein A-II,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,40532,0.0223274363072404,0.0111975137552082,0.000380309347032395,0.0442745632674485,0.0461627089432503
APOA2,Apolipoprotein A-II,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,40569,-0.0025759608458345,0.00913832786065602,-0.0204870834527203,0.0153351617610513,0.778032853296832
APOA2,Apolipoprotein A-II,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,40617,0.0223025776360967,0.0104912522190042,0.00173972328684846,0.042865431985345,0.0335237606101977
APOA2,Apolipoprotein A-II,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,40943,-0.00250657499815007,0.00536925215966956,-0.0130303092311024,0.00801715923480226,0.640617730354001
APOA2,Apolipoprotein A-II,Health and medical history,X20110#9.Illnesses of mother_Diabetes,40679,-0.0344484433927639,0.00829851576935782,-0.0507135343007052,-0.0181833524848226,3.31471571081308e-05
APOA2,Apolipoprotein A-II,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,35086,0.00143795805801014,0.00872953151791061,-0.0156719237170947,0.0185478398331149,0.869162652218991
APOA2,Apolipoprotein A-II,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,34828,-0.0450390270811844,0.0350945381636321,-0.113824321881903,0.0237462677195345,0.199373519695261
APOA2,Apolipoprotein A-II,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,34821,-0.0121291665544623,0.0352376810594689,-0.0811950214310214,0.0569366883220969,0.730690348795049
APOA2,Apolipoprotein A-II,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,34930,0.0130410742627696,0.0103301612528051,-0.00720604179272835,0.0332881903182676,0.206803617943694
APOA2,Apolipoprotein A-II,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,34846,-0.00211556775474758,0.0205713667877761,-0.0424354466587887,0.0382043111492935,0.918090226296897
APOA2,Apolipoprotein A-II,Health and medical history,X20111#2.Illnesses of siblings_Stroke,34892,0.0276902603329831,0.0147008242217061,-0.00112335514156081,0.0565038758075271,0.0596293677048736
APOA2,Apolipoprotein A-II,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,34846,0.0281877954179617,0.0173937182611428,-0.0059038923738781,0.0622794832098016,0.105118234046331
APOA2,Apolipoprotein A-II,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,34851,0.0241273393268428,0.0170084635180894,-0.00920924916861235,0.0574639278222979,0.15603948214837
APOA2,Apolipoprotein A-II,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,34871,0.00306761228320072,0.0127574246223269,-0.0219369399765601,0.0280721645429615,0.809977394542239
APOA2,Apolipoprotein A-II,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,34895,0.0110439506498003,0.0158851815487342,-0.0200910051857187,0.0421789064853193,0.486912023769631
APOA2,Apolipoprotein A-II,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,35199,-4.14867704607116e-05,0.00653080683938226,-0.0128418681756499,0.0127588946347285,0.994931530420003
APOA2,Apolipoprotein A-II,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,35013,0.00166658847693716,0.00922562785774069,-0.0164156421242346,0.0197488190781089,0.856645156561556
APOA2,Apolipoprotein A-II,Mental health,X20127.Neuroticism score,35592,0.0215071030073186,0.0184887398065216,-0.0147308270134638,0.0577450330281009,0.244734212918836
APOA2,Apolipoprotein A-II,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,14555,0.0258888076471487,0.0297477600352336,-0.0324168020219091,0.0841944173162065,0.384163122902438
APOA2,Apolipoprotein A-II,Lifestyle factors,X20161.Pack years of smoking,13762,0.00784419394235491,0.00477270150453906,-0.00151030100654165,0.0171986888912515,0.100291172803466
APOA2,Apolipoprotein A-II,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,13762,0.00722643219765166,0.00470613970606727,-0.00199760162624019,0.0164504660215435,0.124676002002217
APOA2,Apolipoprotein A-II,Cognitive function,X20191.Fluid intelligence score,10824,-0.00395506116017174,0.0352870318465364,-0.0731176435793831,0.0652075212590396,0.910760022095192
APOA2,Apolipoprotein A-II,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,10825,0.00510012697792666,0.0360001216942823,-0.0654601115428667,0.07566036549872,0.887343540256288
APOA2,Apolipoprotein A-II,Cognitive function,X20240.Maximum digits remembered correctly,9715,0.0440396729901927,0.0375853173200474,-0.0296275489571001,0.117706894937486,0.241336100278258
APOA2,Apolipoprotein A-II,Physical measures,X20255.Spirometry QC measure,33231,-0.0237791984172965,0.0237030494487758,-0.0702371753368971,0.0226787785023041,0.315765591073968
APOA2,Apolipoprotein A-II,Eye measures,X20261.avMSE,9969,0.00700597058515719,0.00513764062891466,-0.00306380504751554,0.0170757462178299,0.172706930608147
APOA2,Apolipoprotein A-II,Eye measures,X20262.Myopia diagnosis,9969,-0.0535489485670143,0.0441849833494631,-0.140151515931962,0.0330536187979334,0.225569315374138
APOA2,Apolipoprotein A-II,NMR metabolomics,X20280.Glucose-lactate,24890,-0.0112319731031676,0.00327567539841446,-0.01765229688406,-0.00481164932227529,0.000607008239273299
APOA2,Apolipoprotein A-II,NMR metabolomics,X20281.Spectrometer-corrected alanine,24941,-0.00119913155808513,0.00329113481845968,-0.0076497558022661,0.00525149268609584,0.715598263534372
APOA2,Apolipoprotein A-II,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,13972,-0.00334541417150715,0.0169847881824478,-0.0366355990091048,0.0299447706660905,0.843857547681286
APOA2,Apolipoprotein A-II,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,13970,-0.0443170365317991,0.0334930622879847,-0.109963438616249,0.0213293655526508,0.185800316010782
APOA2,Apolipoprotein A-II,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),13971,0.0143985878348798,0.0416382927222529,-0.0672124659007359,0.0960096415704954,0.729497041963499
APOA2,Apolipoprotein A-II,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),13971,-0.00580829922734137,0.0161351043267941,-0.0374331037078578,0.025816505253175,0.718868261167292
APOA2,Apolipoprotein A-II,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),13971,0.00531063730591569,0.0279295783123791,-0.0494313361863474,0.0600526107981788,0.849199181604108
APOA2,Apolipoprotein A-II,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,13978,-0.0600590288906443,0.0356917445484934,-0.130014848205691,0.00989679042440274,0.0924526597785354
APOA2,Apolipoprotein A-II,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,13978,-0.0421998074600689,0.0237741994499461,-0.0887972383819634,0.0043976234618255,0.0759154749172279
APOA2,Apolipoprotein A-II,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,13978,-0.0617173031126194,0.0262812106531643,-0.113228475992821,-0.0102061302324174,0.0188710054026345
APOA2,Apolipoprotein A-II,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,13978,0.0145590973954801,0.0409053181099022,-0.0656153260999282,0.0947335208908884,0.721904452178929
APOA2,Apolipoprotein A-II,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,13978,-0.00183274265528158,0.0464210257189767,-0.0928179530644759,0.0891524677539128,0.968507566576449
APOA2,Apolipoprotein A-II,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,13978,-0.0273267868234821,0.0277702710097919,-0.0817565180026741,0.02710294435571,0.325117686921458
APOA2,Apolipoprotein A-II,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,13978,0.0209727631651862,0.0466178446680074,-0.0703982123841083,0.112343738714481,0.652798891517642
APOA2,Apolipoprotein A-II,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,13978,-0.00197481263899908,0.0344478630220887,-0.069492624162293,0.0655429988842948,0.954285070687617
APOA2,Apolipoprotein A-II,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),13981,-0.0091600322963006,0.0476308665911264,-0.102516530814908,0.084196466222307,0.847499873780364
APOA2,Apolipoprotein A-II,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),13981,-0.00629689026406606,0.0218301270316528,-0.0490839392461056,0.0364901587179735,0.773006925586199
APOA2,Apolipoprotein A-II,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),13981,-0.0275978277836508,0.0326280173819305,-0.0915487418522347,0.0363530862849331,0.397660848781489
APOA2,Apolipoprotein A-II,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,13982,0.0258353619199404,0.0541531994175453,-0.0803049089384485,0.131975632778329,0.633313230590312
APOA2,Apolipoprotein A-II,Diet and food preferences,X20600.Liking for adding salt to foods,15808,0.00155893109621853,0.0290142359623345,-0.0553089713899571,0.0584268335823941,0.957151065121772
APOA2,Apolipoprotein A-II,Diet and food preferences,X20601.Liking for aniseed,15808,0.0239023760255463,0.0288507788016915,-0.032645150425769,0.0804499024768616,0.407409618438026
APOA2,Apolipoprotein A-II,Diet and food preferences,X20602.Liking for apple juice,15808,-0.0763363175907658,0.0288182594053474,-0.132820106025247,-0.0198525291562849,0.00808376680034248
APOA2,Apolipoprotein A-II,Diet and food preferences,X20603.Liking for apples,15808,-0.0181002041168169,0.029678047097342,-0.0762691764276072,0.0400687681939735,0.541946582043424
APOA2,Apolipoprotein A-II,Diet and food preferences,X20604.Liking for asparagus,15808,0.0376586619207799,0.0292725326908448,-0.0197155021532758,0.0950328259948356,0.198292864592087
APOA2,Apolipoprotein A-II,Diet and food preferences,X20605.Liking for aubergine,15808,0.0307403591777801,0.0287666532313895,-0.0256422811557433,0.0871229995113034,0.285261376556609
APOA2,Apolipoprotein A-II,Diet and food preferences,X20606.Liking for avocados,15808,0.0852716371155793,0.0292808684573553,0.027881134939163,0.142662139291996,0.00359399641372546
APOA2,Apolipoprotein A-II,Diet and food preferences,X20607.Liking for bacon,15808,-0.119422833309567,0.0291992282052669,-0.17665332059189,-0.0621923460272441,4.33641352288934e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20608.Liking for baked or steamed fish,15808,-0.0191785376306921,0.0294938122545081,-0.0769864096495279,0.0386293343881438,0.515536134492497
APOA2,Apolipoprotein A-II,Diet and food preferences,X20609.Liking for bananas,15808,-0.0226362056211412,0.0299647851319895,-0.0813671844798406,0.0360947732375582,0.450004131977621
APOA2,Apolipoprotein A-II,Diet and food preferences,X20610.Liking for barbequed or grilled meat,15808,-0.204655297132556,0.0291818683149746,-0.261851759029906,-0.147458835235205,2.42556572485868e-12
APOA2,Apolipoprotein A-II,Diet and food preferences,X20611.Liking for beef steak,15808,-0.195191571703235,0.0293566856371001,-0.252730675551951,-0.137652467854519,3.0484495986611e-11
APOA2,Apolipoprotein A-II,Diet and food preferences,X20612.Liking for beetroot,15808,0.00391142221394853,0.0293011648117229,-0.0535188608170283,0.0613417052449253,0.893807311618151
APOA2,Apolipoprotein A-II,Diet and food preferences,X20613.Liking for bell pepper,15808,-0.00470527419598356,0.0289461586065621,-0.0614397450648453,0.0520291966728782,0.870872767682729
APOA2,Apolipoprotein A-II,Diet and food preferences,X20614.Liking for bicycling,15808,0.0666028824325509,0.0287765914253912,0.0102007632387841,0.123005001626318,0.0206541052582366
APOA2,Apolipoprotein A-II,Diet and food preferences,X20615.Liking for biscuits,15808,-0.0607721263267886,0.028968797825815,-0.117550970065386,-0.00399328258819116,0.0359344577785465
APOA2,Apolipoprotein A-II,Diet and food preferences,X20616.Liking for bitter foods,15808,0.0281532309539976,0.0288071486026894,-0.0283087803072736,0.0846152422152687,0.328435550764495
APOA2,Apolipoprotein A-II,Diet and food preferences,X20617.Liking for bitter or ale,15808,0.0154760638266562,0.0295042232604103,-0.042352213763748,0.0733043414170605,0.599912291312133
APOA2,Apolipoprotein A-II,Diet and food preferences,X20618.Liking for black olives,15808,0.0405370019745408,0.0292049565217346,-0.0167047128080589,0.0977787167571405,0.165151189050292
APOA2,Apolipoprotein A-II,Diet and food preferences,X20619.Liking for black pepper,15808,0.0579564559419821,0.0292890864116015,0.00054984657524304,0.115363065308721,0.0478589124943109
APOA2,Apolipoprotein A-II,Diet and food preferences,X20620.Liking for blue cheese,15808,0.069963333767965,0.0288954600776132,0.0133282320158431,0.126598435520087,0.0154781391572612
APOA2,Apolipoprotein A-II,Diet and food preferences,X20621.Liking for bolognese sauce,15808,-0.102140984539943,0.0290626602832727,-0.159103798695158,-0.0451781703847285,0.00044180142955224
APOA2,Apolipoprotein A-II,Diet and food preferences,X20622.Liking for broad beans,15808,0.0382517956021075,0.0291921756475346,-0.0189648686670603,0.0954684598712753,0.190098515587409
APOA2,Apolipoprotein A-II,Diet and food preferences,X20623.Liking for broccoli,15808,-0.00211575632094259,0.0299197909292858,-0.0607585465423428,0.0565270339004576,0.943626055364347
APOA2,Apolipoprotein A-II,Diet and food preferences,X20624.Liking for brown rice,15808,0.00635090813472155,0.0290390382920351,-0.0505656069176672,0.0632674231871103,0.82688468617043
APOA2,Apolipoprotein A-II,Diet and food preferences,X20625.Liking for brussel sprouts,15808,0.0159745337802357,0.0292240641238191,-0.0413046319024497,0.0732536994629211,0.584645768735431
APOA2,Apolipoprotein A-II,Diet and food preferences,X20626.Liking for burgers (meat),15808,-0.168975837975915,0.0289623438450553,-0.225742031912223,-0.112209644039606,5.50648782785982e-09
APOA2,Apolipoprotein A-II,Diet and food preferences,X20627.Liking for burn of spicy foods,15808,-0.00207223815533808,0.0286167625690957,-0.0581610927907656,0.0540166164800894,0.942273808533028
APOA2,Apolipoprotein A-II,Diet and food preferences,X20628.Liking for butter on bread,15808,-0.0349008073401888,0.0294330110808777,-0.092589509058709,0.0227878943783314,0.235730644789318
APOA2,Apolipoprotein A-II,Diet and food preferences,X20629.Liking for butternut squash,15808,-0.00290185690512904,0.0289687912164011,-0.0596806876892752,0.0538769738790171,0.920209179960664
APOA2,Apolipoprotein A-II,Diet and food preferences,X20630.Liking for cabbage,15808,0.00287323568257764,0.0292951040764577,-0.0545451683072794,0.0602916396724347,0.921870776288986
APOA2,Apolipoprotein A-II,Diet and food preferences,X20631.Liking for cake,15808,-0.0115602126989948,0.0289535899783057,-0.0683092490564739,0.0451888236584843,0.689701889357254
APOA2,Apolipoprotein A-II,Diet and food preferences,X20632.Liking for cake icing,15808,-0.0219280927642384,0.0288011769470888,-0.0783783995805326,0.0345222140520557,0.446452851467439
APOA2,Apolipoprotein A-II,Diet and food preferences,X20633.Liking for capers,15808,0.0164955272519327,0.0288290374689257,-0.0400093861871617,0.073000440691027,0.567205162370967
APOA2,Apolipoprotein A-II,Diet and food preferences,X20634.Liking for cauliflower,15808,0.0347969439197303,0.0295921783652337,-0.0232037256761277,0.0927976135155883,0.239659307189297
APOA2,Apolipoprotein A-II,Diet and food preferences,X20635.Liking for cereal or granola bar,15808,-0.0210504100666933,0.0287765367126824,-0.0774524220235507,0.0353516018901642,0.464476739504914
APOA2,Apolipoprotein A-II,Diet and food preferences,X20636.Liking for cheesecake,15808,-0.0281940097168524,0.0288644419511549,-0.0847683159411161,0.0283802965074112,0.328696477578346
APOA2,Apolipoprotein A-II,Diet and food preferences,X20637.Liking for cherries,15808,0.000173385698849625,0.030621814139465,-0.0598453700145019,0.0601921414122011,0.99548234336178
APOA2,Apolipoprotein A-II,Diet and food preferences,X20638.Liking for chicken,15808,-0.170786114599954,0.0302755359806106,-0.230126165121951,-0.111446064077957,1.71905915375331e-08
APOA2,Apolipoprotein A-II,Diet and food preferences,X20639.Liking for chilli pepper,15808,0.00881592171164286,0.0288993391859223,-0.0478267830927648,0.0654586265160506,0.760327394806044
APOA2,Apolipoprotein A-II,Diet and food preferences,X20640.Liking for chips or french fries,15808,-0.0272246366240597,0.0292345234300339,-0.084524302546926,0.0300750292988067,0.351738737136181
APOA2,Apolipoprotein A-II,Diet and food preferences,X20641.Liking for cigarette smoking,15808,-0.00128371993039668,0.0468356929857599,-0.093081678182486,0.0905142383216927,0.978133859297506
APOA2,Apolipoprotein A-II,Diet and food preferences,X20642.Liking for cod,15808,-0.0598356153911719,0.0297405204907864,-0.118127035553113,-0.00154419522923052,0.0442450904057936
APOA2,Apolipoprotein A-II,Diet and food preferences,X20643.Liking for coffee with sugar,15808,-0.0749405406009431,0.0316290188306273,-0.136933417508973,-0.0129476636929137,0.0178308468324816
APOA2,Apolipoprotein A-II,Diet and food preferences,X20644.Liking for coffee without sugar,15808,0.0182246429700235,0.0295602875871889,-0.0397135207008668,0.0761628066409138,0.537557265890547
APOA2,Apolipoprotein A-II,Diet and food preferences,X20645.Liking for coriander,15808,0.000632675757938859,0.0289481713677313,-0.0561057401228146,0.0573710916386923,0.982563525982739
APOA2,Apolipoprotein A-II,Diet and food preferences,X20646.Liking for corn flakes,15808,-0.0515635078313664,0.0288848438120536,-0.108177801702992,0.00505078604025871,0.0742577069188592
APOA2,Apolipoprotein A-II,Diet and food preferences,X20647.Liking for cream,15808,-0.0981699947986004,0.0289317142036334,-0.154876154637722,-0.0414638349594791,0.000692605029879232
APOA2,Apolipoprotein A-II,Diet and food preferences,X20648.Liking for croissant,15808,0.0176968533553468,0.0289040153869097,-0.0389550168029964,0.0743487235136899,0.540372717726357
APOA2,Apolipoprotein A-II,Diet and food preferences,X20649.Liking for cucumber,15808,-0.0155895978134862,0.0291777962279599,-0.0727780784202877,0.0415988827933153,0.59314385713388
APOA2,Apolipoprotein A-II,Diet and food preferences,X20650.Liking for curry,15808,-0.0159316705907238,0.0292688967059924,-0.0732987081344688,0.0414353669530212,0.586228393590172
APOA2,Apolipoprotein A-II,Diet and food preferences,X20651.Liking for dairy products,15808,-0.0867629881919468,0.0293849401236533,-0.144357470834307,-0.0291685055495864,0.00315538740262792
APOA2,Apolipoprotein A-II,Diet and food preferences,X20652.Liking for dark chocolate,15808,-0.03241481644819,0.0291198425661934,-0.089489707877929,0.024660074981549,0.265660024067868
APOA2,Apolipoprotein A-II,Diet and food preferences,X20653.Liking for diet fizzy drinks,15808,-0.0414388849359183,0.0297547587698823,-0.0997582121248876,0.016880442253051,0.163735914832309
APOA2,Apolipoprotein A-II,Diet and food preferences,X20654.Liking for dried fruit,15808,-0.0541725771228043,0.0291252770993458,-0.111258120237522,0.00291296599191337,0.0629062420520767
APOA2,Apolipoprotein A-II,Diet and food preferences,X20655.Liking for eggs,15808,-0.0154498201131634,0.0298664927740351,-0.0739881459502721,0.0430885057239454,0.60495672732528
APOA2,Apolipoprotein A-II,Diet and food preferences,X20656.Liking for exercising alone,15808,0.127650236935117,0.0288347192014118,0.0711341873003498,0.184166286569884,9.62103211792769e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20657.Liking for exercising with others,15808,0.0510638666041928,0.0288038905715022,-0.00539175891595148,0.107519492124337,0.0762792391034533
APOA2,Apolipoprotein A-II,Diet and food preferences,X20658.Liking for extra virgin olive oil,15808,0.0161490498236383,0.0294312802915451,-0.0415362595477901,0.0738343591950668,0.583216627057083
APOA2,Apolipoprotein A-II,Diet and food preferences,X20659.Liking for fatty foods,15808,-0.032771772406149,0.0289569013395725,-0.0895272990317111,0.0239837542194132,0.25775966111896
APOA2,Apolipoprotein A-II,Diet and food preferences,X20660.Liking for fresh tomatoes,15808,-0.0111943856961962,0.0310647541592463,-0.072081303848319,0.0496925324559266,0.718585383285584
APOA2,Apolipoprotein A-II,Diet and food preferences,X20661.Liking for fried chicken,15808,-0.160160040442308,0.0288018489305159,-0.216611664346119,-0.103708416538497,2.72966103667044e-08
APOA2,Apolipoprotein A-II,Diet and food preferences,X20662.Liking for fried or battered fish,15808,-0.0804772562800438,0.0291621918004454,-0.137635152208917,-0.0233193603511707,0.00579311562908852
APOA2,Apolipoprotein A-II,Diet and food preferences,X20663.Liking for fruit,15808,-0.0367007606490172,0.0323417221989497,-0.100090536158959,0.0266890148609242,0.256484465545768
APOA2,Apolipoprotein A-II,Diet and food preferences,X20664.Liking for garlic,15808,0.0264911598131168,0.0293439001247856,-0.0310228844314631,0.0840052040576966,0.36665511105415
APOA2,Apolipoprotein A-II,Diet and food preferences,X20665.Liking for gherkins,15808,0.0325860934822402,0.028870445824684,-0.0239999803341405,0.0891721672986209,0.259041251761775
APOA2,Apolipoprotein A-II,Diet and food preferences,X20666.Liking for globe artichoke,15808,0.0958304560939745,0.0289993896291068,0.0389916524209253,0.152669259767024,0.00095334738664439
APOA2,Apolipoprotein A-II,Diet and food preferences,X20667.Liking for goat's cheese,15808,0.0296253983352416,0.0289009264617937,-0.0270204175298741,0.0862712142003573,0.305347081684423
APOA2,Apolipoprotein A-II,Diet and food preferences,X20668.Liking for going to a cafe,15808,0.00639893000900703,0.0291004593040492,-0.0506379702269293,0.0634358302449434,0.825958864787338
APOA2,Apolipoprotein A-II,Diet and food preferences,X20669.Liking for going to the gym,15808,0.0388864094390712,0.0287421589102226,-0.0174482220249651,0.0952210409031074,0.176094254459156
APOA2,Apolipoprotein A-II,Diet and food preferences,X20670.Liking for going to the pub,15808,0.0204630686363476,0.0291073782256906,-0.0365873926860059,0.0775135299587011,0.482053662315873
APOA2,Apolipoprotein A-II,Diet and food preferences,X20671.Liking for grapefruit,15808,0.0128381188321305,0.0288145198509714,-0.0436383400757733,0.0693145777400344,0.655933221273914
APOA2,Apolipoprotein A-II,Diet and food preferences,X20672.Liking for green olives,15808,0.0519108934432709,0.0292528813141597,-0.00542475393248214,0.109246540819024,0.0759903989698454
APOA2,Apolipoprotein A-II,Diet and food preferences,X20673.Liking for haddock,15808,0.00606687825890634,0.0297647772776569,-0.0522720852053012,0.0644058417231139,0.838490979003344
APOA2,Apolipoprotein A-II,Diet and food preferences,X20674.Liking for ham,15808,-0.188115225364941,0.0292222322686612,-0.245390800611517,-0.130839650118365,1.25043739419942e-10
APOA2,Apolipoprotein A-II,Diet and food preferences,X20675.Liking for hard cheese,15808,0.0137632505790022,0.0297333441215856,-0.0445141038993056,0.07204060505731,0.643450008639244
APOA2,Apolipoprotein A-II,Diet and food preferences,X20676.Liking for herring,15808,0.0470967184497634,0.0290486341192213,-0.00983860442391037,0.104032041323437,0.104972048514579
APOA2,Apolipoprotein A-II,Diet and food preferences,X20677.Liking for honey,15808,-0.0167230292049293,0.0290097545627987,-0.0735821481480147,0.0401360897381561,0.564310979278667
APOA2,Apolipoprotein A-II,Diet and food preferences,X20678.Liking for horseradish or wasabi,15808,-0.0164012999857124,0.0289152596916393,-0.0730752089813255,0.0402726090099006,0.57057310752821
APOA2,Apolipoprotein A-II,Diet and food preferences,X20679.Liking for ice cream,15808,-0.0517261622642542,0.0290841891345311,-0.108731172967935,0.00527884843942675,0.0753413984012321
APOA2,Apolipoprotein A-II,Diet and food preferences,X20680.Liking for jam,15808,-0.0553867118818533,0.0288390677438589,-0.111911284659817,0.00113786089611021,0.0548071576408644
APOA2,Apolipoprotein A-II,Diet and food preferences,X20681.Liking for kiwi fruit,15808,-0.0364371318810304,0.0291076582848144,-0.0934881421192667,0.0206138783572058,0.210659230073284
APOA2,Apolipoprotein A-II,Diet and food preferences,X20682.Liking for lager,15808,-0.0370455592926774,0.0290207159746849,-0.0939261626030598,0.019835044017705,0.201790115842558
APOA2,Apolipoprotein A-II,Diet and food preferences,X20683.Liking for lamb,15808,-0.145357180585399,0.0295709575558637,-0.203316257394892,-0.087398103775906,8.94276844127675e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20684.Liking for lemons,15808,0.0144038070195765,0.0288511429888451,-0.0421444332385598,0.0709520472777128,0.617613311336878
APOA2,Apolipoprotein A-II,Diet and food preferences,X20685.Liking for lentils or beans,15808,0.0449188623106157,0.0293118275325821,-0.0125323196532451,0.102370044274477,0.125431869480375
APOA2,Apolipoprotein A-II,Diet and food preferences,X20686.Liking for liver,15808,-0.122907584423503,0.0292088818943705,-0.180156992936469,-0.065658175910537,2.59197825636207e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20687.Liking for mackerel,15808,0.0829942060481712,0.029090031926277,0.0259777434726682,0.140010668623674,0.00433633044842785
APOA2,Apolipoprotein A-II,Diet and food preferences,X20688.Liking for marzipan,15808,0.00562770226137808,0.0287072713685354,-0.0506385496209513,0.0618939541437075,0.844583323158367
APOA2,Apolipoprotein A-II,Diet and food preferences,X20689.Liking for mayonnaise,15808,0.0440369079737567,0.0288753546988209,-0.0125587872359322,0.100632603183446,0.127261925500234
APOA2,Apolipoprotein A-II,Diet and food preferences,X20690.Liking for melon,15808,-0.0686294179097255,0.0299597334139239,-0.127350495401016,-0.00990834041843464,0.0219926208524158
APOA2,Apolipoprotein A-II,Diet and food preferences,X20691.Liking for milk chocolate,15808,-0.0244131251948832,0.0289523792739893,-0.0811597885719022,0.0323335381821359,0.399120124330158
APOA2,Apolipoprotein A-II,Diet and food preferences,X20692.Liking for mushrooms,15808,-0.0122224306920143,0.0300301822953179,-0.0710815879908375,0.0466367266068089,0.68400992383479
APOA2,Apolipoprotein A-II,Diet and food preferences,X20694.Liking for orange juice,15808,-0.0457853113931491,0.0291394382925999,-0.102898610446645,0.0113279876603468,0.116144880291901
APOA2,Apolipoprotein A-II,Diet and food preferences,X20695.Liking for oranges,15808,-0.0741795121362096,0.0295637277957613,-0.132124418615902,-0.0162346056565175,0.0121125092148723
APOA2,Apolipoprotein A-II,Diet and food preferences,X20696.Liking for pasta,15808,-0.0369535468139528,0.0294258408861401,-0.0946281949507874,0.0207211013228818,0.209199982667471
APOA2,Apolipoprotein A-II,Diet and food preferences,X20697.Liking for pears,15808,-0.0183393461636722,0.0295784884833196,-0.0763131835909787,0.0396344912636343,0.535251528011734
APOA2,Apolipoprotein A-II,Diet and food preferences,X20698.Liking for pizza,15808,-0.0746899370015101,0.028949265208474,-0.131430496810119,-0.017949377192901,0.00988816058628679
APOA2,Apolipoprotein A-II,Diet and food preferences,X20699.Liking for plain yogurt,15808,-0.00933117297707969,0.0291614982170502,-0.0664877094824982,0.0478253635283388,0.748985731016389
APOA2,Apolipoprotein A-II,Diet and food preferences,X20700.Liking for plums,15808,-0.0189088342745968,0.0296812256373079,-0.0770840365237203,0.0392663679745268,0.524092528537527
APOA2,Apolipoprotein A-II,Diet and food preferences,X20701.Liking for pollock,15808,0.0159999723504983,0.0288245801462341,-0.0404962047361205,0.0724961494371171,0.578847228477827
APOA2,Apolipoprotein A-II,Diet and food preferences,X20702.Liking for pork chop,15808,-0.200331670693404,0.0290433797038337,-0.257256694912918,-0.143406646473889,5.48694698944588e-12
APOA2,Apolipoprotein A-II,Diet and food preferences,X20703.Liking for porridge,15808,-0.0228416667561284,0.0294194952359737,-0.0805038774186367,0.03482054390638,0.437517041405628
APOA2,Apolipoprotein A-II,Diet and food preferences,X20704.Liking for potato crisps,15808,0.0101967299906581,0.0291002596251863,-0.046839778874707,0.0672332388560232,0.726043227224808
APOA2,Apolipoprotein A-II,Diet and food preferences,X20705.Liking for potatoes,15808,0.0161690914461662,0.0294056874664055,-0.0414660559879886,0.0738042388803211,0.582421311368644
APOA2,Apolipoprotein A-II,Diet and food preferences,X20706.Liking for prawns,15808,-0.0146106602928417,0.0295472969781232,-0.0725233623699632,0.0433020417842797,0.620971411708551
APOA2,Apolipoprotein A-II,Diet and food preferences,X20707.Liking for raw carrots,15808,0.0815342174241983,0.02926548099842,0.0241738746672951,0.138894560181101,0.00534232274936211
APOA2,Apolipoprotein A-II,Diet and food preferences,X20708.Liking for red meat,15808,-0.208459170100657,0.0293545167381168,-0.265994022907365,-0.150924317293948,1.28735886378836e-12
APOA2,Apolipoprotein A-II,Diet and food preferences,X20709.Liking for red wine,15808,0.00961962334061192,0.0291541759051558,-0.0475225614334934,0.0667618081147172,0.741436859698445
APOA2,Apolipoprotein A-II,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,15808,-0.0759671612977596,0.0298822630418429,-0.134536396859772,-0.0173979257357476,0.0110246858686889
APOA2,Apolipoprotein A-II,Diet and food preferences,X20711.Liking for roast chicken,15808,-0.184717891256284,0.0304078087252705,-0.244317196357814,-0.125118586154753,1.2708129543232e-09
APOA2,Apolipoprotein A-II,Diet and food preferences,X20712.Liking for salad dressing,15808,-0.014368221160228,0.0289107116208892,-0.0710332159371708,0.0422967736167148,0.619205791027881
APOA2,Apolipoprotein A-II,Diet and food preferences,X20713.Liking for salad leaves,15808,0.0322418114436238,0.0297992548641068,-0.0261647280900255,0.0906483509772731,0.279283704172181
APOA2,Apolipoprotein A-II,Diet and food preferences,X20714.Liking for salami,15808,-0.0833525725819536,0.0289366957948419,-0.140068496339844,-0.0266366488240635,0.00397561050828191
APOA2,Apolipoprotein A-II,Diet and food preferences,X20715.Liking for salmon,15808,-0.014792929825005,0.030446008992023,-0.0744671074493701,0.0448812477993601,0.62706311627494
APOA2,Apolipoprotein A-II,Diet and food preferences,X20716.Liking for salty foods,15808,0.0264742299391594,0.0288565109362965,-0.0300845314959818,0.0830329913743006,0.358924094302149
APOA2,Apolipoprotein A-II,Diet and food preferences,X20717.Liking for salty pretzels,15808,-0.024294386899552,0.0288048498905917,-0.0807518926851118,0.0321631188860078,0.399010244583681
APOA2,Apolipoprotein A-II,Diet and food preferences,X20718.Liking for sardines,15808,0.0621632764931615,0.0290501555755874,0.0052249715650102,0.119101581421313,0.0323813387371936
APOA2,Apolipoprotein A-II,Diet and food preferences,X20719.Liking for sausages (meat),15808,-0.137794413129923,0.029130727979817,-0.194890639970364,-0.0806981862894815,2.26230821029164e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20720.Liking for savoury biscuits,15808,0.0160810848408267,0.0289765799840348,-0.0407130119278814,0.0728751816095348,0.578924171369717
APOA2,Apolipoprotein A-II,Diet and food preferences,X20721.Liking for shellfish (other than prawns),15808,0.0256152205973422,0.0290497772158243,-0.0313223427456734,0.0825527839403578,0.377914651610911
APOA2,Apolipoprotein A-II,Diet and food preferences,X20722.Liking for skimmed milk,15808,-0.0195058324685153,0.0289001700509803,-0.0761501657684367,0.037138500831406,0.499724833282221
APOA2,Apolipoprotein A-II,Diet and food preferences,X20723.Liking for smoked fish,15808,0.0453668025003203,0.0292088129358999,-0.0118824708540435,0.102616075854684,0.120398072839959
APOA2,Apolipoprotein A-II,Diet and food preferences,X20724.Liking for soft cheese,15808,-0.0307084618045426,0.0288711340366268,-0.0872958845163311,0.025878960907246,0.287508575203909
APOA2,Apolipoprotein A-II,Diet and food preferences,X20725.Liking for soy sauce,15808,-0.0420263519552031,0.0290884277844484,-0.099039670412722,0.0149869665023157,0.148539798410083
APOA2,Apolipoprotein A-II,Diet and food preferences,X20726.Liking for soya milk,15808,0.0289262653127628,0.0290310995021179,-0.0279746897113882,0.0858272203369138,0.319076497356126
APOA2,Apolipoprotein A-II,Diet and food preferences,X20727.Liking for spicy foods,15808,-0.00789474698779829,0.0290250239102316,-0.0647837938518522,0.0489942998762557,0.785627153366589
APOA2,Apolipoprotein A-II,Diet and food preferences,X20728.Liking for spinach,15808,0.0223099560554597,0.0294039487034345,-0.0353217834032719,0.0799416955141913,0.448019350947432
APOA2,Apolipoprotein A-II,Diet and food preferences,X20729.Liking for spirits,15808,0.0386431543305751,0.028959291301859,-0.0181170566210685,0.0954033652822186,0.182093450970861
APOA2,Apolipoprotein A-II,Diet and food preferences,X20730.Liking for strawberries,15808,-0.120393749608823,0.0315364276299684,-0.182205147763561,-0.0585823514540853,0.000135266096778808
APOA2,Apolipoprotein A-II,Diet and food preferences,X20731.Liking for sweet coffee house drinks,15808,-0.0941451870231449,0.0297164681289096,-0.152389464555808,-0.0359009094904821,0.00153723273249026
APOA2,Apolipoprotein A-II,Diet and food preferences,X20732.Liking for sweet foods,15808,-0.0380060808770908,0.0287302308284137,-0.0943173333007817,0.0183051715466002,0.185901013432347
APOA2,Apolipoprotein A-II,Diet and food preferences,X20733.Liking for taking the stairs,15808,0.0452095925372799,0.0297176364616088,-0.0130369749274733,0.103456160002033,0.128203316078402
APOA2,Apolipoprotein A-II,Diet and food preferences,X20734.Liking for tea with sugar,15808,-0.0440617668913722,0.0348983614786411,-0.112462555389509,0.0243390216067643,0.206760936931191
APOA2,Apolipoprotein A-II,Diet and food preferences,X20735.Liking for tea without sugar,15808,-0.00465794356045947,0.0302168393677109,-0.0638829487211728,0.0545670616002539,0.877492972034343
APOA2,Apolipoprotein A-II,Diet and food preferences,X20736.Liking for tomato ketchup,15808,-0.0594120457762031,0.0288222689914822,-0.115903692999508,-0.00292039855289793,0.0392884421415758
APOA2,Apolipoprotein A-II,Diet and food preferences,X20737.Liking for tinned tuna,15808,-0.0235739197332841,0.0291572568535826,-0.0807221431663061,0.0335743036997378,0.418809513015101
APOA2,Apolipoprotein A-II,Diet and food preferences,X20738.Liking for turnip (white),15808,0.0298004924081459,0.0288961598853074,-0.0268359809670567,0.0864369657833484,0.302417861898565
APOA2,Apolipoprotein A-II,Diet and food preferences,X20739.Liking for vegetables,15808,0.0411557090239735,0.0319758936834659,-0.0215170425956197,0.103828460643567,0.198083362549749
APOA2,Apolipoprotein A-II,Diet and food preferences,X20740.Liking for vinegar,15808,-0.0929966757624508,0.0288211274783187,-0.149486085619955,-0.0365072659049462,0.0012548897682124
APOA2,Apolipoprotein A-II,Diet and food preferences,X20741.Liking for watching television,15808,-0.0521921393365982,0.0292732234586674,-0.109567657315586,0.00518337864238987,0.0746167373008392
APOA2,Apolipoprotein A-II,Diet and food preferences,X20742.Liking for whisky,15808,0.0329491633426403,0.0298858196423411,-0.0256270431563483,0.0915253698416289,0.270260481249216
APOA2,Apolipoprotein A-II,Diet and food preferences,X20743.Liking for white bread,15808,-0.0214578491223504,0.0288749214022677,-0.0780526950707951,0.0351369968260944,0.457413434440246
APOA2,Apolipoprotein A-II,Diet and food preferences,X20744.Liking for white rice,15808,-0.0468486878687764,0.0289956499947855,-0.103680161858556,0.00998278612100308,0.106176071047283
APOA2,Apolipoprotein A-II,Diet and food preferences,X20745.Liking for white wine,15808,0.0141800366510217,0.0288330610174779,-0.042332762943235,0.0706928362452783,0.622869114050562
APOA2,Apolipoprotein A-II,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,15808,-0.0556386882048118,0.0293628227353955,-0.113189820766187,0.00191244435656338,0.0581280800318599
APOA2,Apolipoprotein A-II,Diet and food preferences,X20747.Liking for whole milk,15808,-0.078415980570273,0.0289666423092851,-0.135190599496472,-0.0216413616440743,0.00679441269674732
APOA2,Apolipoprotein A-II,Diet and food preferences,X20748.Liking for wholemeal bread,15808,0.00954121679190519,0.0303884303955527,-0.0500201067833781,0.0691025403671885,0.753543941634704
APOA2,Apolipoprotein A-II,Diet and food preferences,X20749.Liking for working up a sweat,15808,0.100068007596442,0.0288313466767024,0.0435585681101058,0.156577447082779,0.000520285928200616
APOA2,Apolipoprotein A-II,Physical measures,X21001.Body mass index (BMI),44601,-0.193659403538658,0.0104037982123514,-0.214050848034867,-0.173267959042449,4.82577994184863e-77
APOA2,Apolipoprotein A-II,Physical measures,X21002.Weight,44635,-0.0452337681960999,0.00590467422433035,-0.0568069296757874,-0.0336606067164125,1.88687306948643e-14
APOA2,Apolipoprotein A-II,Physical measures,X21021.Pulse wave Arterial Stiffness index,15049,-0.015530514765295,0.00430161902303234,-0.0239616880504383,-0.00709934148015158,0.000306733290812696
APOA2,Apolipoprotein A-II,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,15163,0.0312383659191675,0.0308337313192932,-0.0291957474666471,0.0916724793049821,0.311017544684161
APOA2,Apolipoprotein A-II,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,15179,0.0134208886495203,0.0320899359592055,-0.0494753858305225,0.0763171631295632,0.675786829345657
APOA2,Apolipoprotein A-II,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,15182,-0.00171655477062204,0.0315295084916582,-0.0635143914142721,0.0600812818730281,0.956583095935086
APOA2,Apolipoprotein A-II,Health and medical history,X21040.Satisfaction with bowel habits,15110,-0.0088845159336383,0.0292774990384779,-0.066268414049055,0.0484993821817784,0.761544393806516
APOA2,Apolipoprotein A-II,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,15092,-0.0405805702869692,0.0312087547576359,-0.101749729611936,0.0205885890379972,0.193519959588863
APOA2,Apolipoprotein A-II,Health and medical history,X21042.Greatest number of times bowels opened per day,15104,-0.0345240636373344,0.0315597356344035,-0.0963811454807652,0.0273330182060965,0.274004226368203
APOA2,Apolipoprotein A-II,Health and medical history,X21043.Least number of times bowels opened per week,14992,-0.0383057473055457,0.0315562119178777,-0.100155922664586,0.0235444280534945,0.224809149026389
APOA2,Apolipoprotein A-II,Health and medical history,X21044.Average number of times bowels opened per day,15054,-0.0209191999335951,0.0351504416557015,-0.08981406557877,0.0479756657115798,0.551763299320892
APOA2,Apolipoprotein A-II,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,15187,0.00202224800364734,0.031843086657925,-0.0603902018458857,0.0644346978531803,0.949363894504956
APOA2,Apolipoprotein A-II,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,15176,-0.0198850860192262,0.0320264202356527,-0.0826568696811054,0.042886697642653,0.534677185732861
APOA2,Apolipoprotein A-II,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,8544,0.0271089147163967,0.049949003324876,-0.0707911318003603,0.125008961233154,0.587328626602378
APOA2,Apolipoprotein A-II,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,15183,0.0260677822899157,0.0347832438457245,-0.0421073756477043,0.0942429402275357,0.453606651161153
APOA2,Apolipoprotein A-II,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,15180,0.0958357499669509,0.0475756687548662,0.00258743920741318,0.189084060726489,0.043986668267426
APOA2,Apolipoprotein A-II,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,15180,0.0306936629132062,0.037339213531168,-0.0424911956078831,0.103878521434296,0.411077178825526
APOA2,Apolipoprotein A-II,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,15178,-0.184852434143746,0.0913659715899216,-0.363929738459993,-0.0057751298275002,0.0430691390609086
APOA2,Apolipoprotein A-II,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,15186,0.0222377318145686,0.0364701006114412,-0.0492436653838561,0.0937191290129934,0.542034961574994
APOA2,Apolipoprotein A-II,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,15183,0.00262110694942475,0.0360469174915312,-0.0680308513339765,0.073273065232826,0.94203485646127
APOA2,Apolipoprotein A-II,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,14821,0.032693400270513,0.0332384983839864,-0.0324540565621004,0.0978408571031263,0.325328102319975
APOA2,Apolipoprotein A-II,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,15179,0.0218226563821647,0.0325178719829066,-0.0419123727043323,0.0855576854686617,0.502168762978389
APOA2,Apolipoprotein A-II,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,15183,-0.00170982607948467,0.0472399906960124,-0.0943002078436689,0.0908805556846996,0.971127777545668
APOA2,Apolipoprotein A-II,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,15187,0.0169514950170845,0.0317491791387971,-0.0452768960949579,0.0791798861291268,0.593405288494748
APOA2,Apolipoprotein A-II,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,15185,0.00375743986077663,0.0318155776793231,-0.0586010923906966,0.0661159721122498,0.905989485577505
APOA2,Apolipoprotein A-II,Working and living environment,X21100.Water hardness (USGS classification),44369,-0.00933158943516513,0.0179008454330796,-0.0444172464840012,0.0257540676136709,0.602165123042226
APOA2,Apolipoprotein A-II,Lifestyle factors,X2139.Age first had sexual intercourse,38688,0.00170322384280495,0.00270070938470378,-0.00359016655121446,0.00699661423682436,0.528267926074916
APOA2,Apolipoprotein A-II,Health and medical history,X2149.Lifetime number of sexual partners,35882,-0.0125288114571987,0.0203059913968532,-0.052328554595031,0.0272709316806335,0.537238162613314
APOA2,Apolipoprotein A-II,Physical activities,X22032.IPAQ activity group,35854,0.0694011976745543,0.0199270297614586,0.0303442193420955,0.108458176007013,0.000496851933387266
APOA2,Apolipoprotein A-II,Physical activities,X22033.Summed days activity,36804,0.0093561535169241,0.00263127502014373,0.00419885447744239,0.0145134525564058,0.000377376622251477
APOA2,Apolipoprotein A-II,Physical activities,X22034.Summed minutes activity,35854,0.00395410127502662,0.00265180814619139,-0.00124344269150851,0.00915164524156175,0.135945018479857
APOA2,Apolipoprotein A-II,Physical activities,X22037.MET minutes per week for walking,34326,0.00253174618911821,0.00270687208057852,-0.00277372308881569,0.00783721546705212,0.349638635600238
APOA2,Apolipoprotein A-II,Physical activities,X22038.MET minutes per week for moderate activity,35854,0.00807731944617744,0.00265519649143275,0.00287313432296924,0.0132815045693856,0.00235119524916558
APOA2,Apolipoprotein A-II,Physical activities,X22039.MET minutes per week for vigorous activity,35854,0.0596432405285808,0.0199697255352542,0.0205025784794825,0.0987839025776791,0.00282212633346482
APOA2,Apolipoprotein A-II,Physical activities,X22040.Summed MET minutes per week for all activity,34326,0.0079183358811485,0.00271550841459323,0.00259593938854576,0.0132407323737512,0.00354816258726251
APOA2,Apolipoprotein A-II,Eye measures,X2217.Age started wearing glasses or contact lenses,38059,-0.00701389735086659,0.00263679364362623,-0.012182012892374,-0.00184578180935918,0.00781710921007766
APOA2,Apolipoprotein A-II,Working and living environment,X22501.Year ended full time education,10609,0.012581881905988,0.011840463417728,-0.0106254263927587,0.0357891902047348,0.287979733080893
APOA2,Apolipoprotein A-II,Lifestyle factors,X22506.Tobacco smoking,10545,0.101312946804829,0.0756883855126605,-0.0470362887999854,0.249662182409644,0.180745002358901
APOA2,Apolipoprotein A-II,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,41891,0.0789652531731636,0.0471691422980187,-0.013486265730953,0.17141677207728,0.0941209483424963
APOA2,Apolipoprotein A-II,Physical measures,X23098.Weight,43887,-0.0423277504423417,0.00595011108332792,-0.0539899681656644,-0.030665532719019,1.14635312049769e-12
APOA2,Apolipoprotein A-II,Physical measures,X23099.Body fat percentage,43857,-0.0208207842197438,0.00571864183328641,-0.0320293222129851,-0.00961224622650242,0.00027203955305558
APOA2,Apolipoprotein A-II,Physical measures,X23100.Whole body fat mass,43812,-0.0462678402287682,0.00551591046540401,-0.0570790247409601,-0.0354566557165764,5.08744060288763e-17
APOA2,Apolipoprotein A-II,Physical measures,X23101.Whole body fat-free mass,43882,-0.0289287805850862,0.00497510271809929,-0.0386799819125608,-0.0191775792576116,6.11590812683356e-09
APOA2,Apolipoprotein A-II,Physical measures,X23102.Whole body water mass,43887,-0.0288669880953047,0.00498183617102794,-0.0386313869905194,-0.0191025892000899,6.90140606773705e-09
APOA2,Apolipoprotein A-II,Physical measures,X23104.Body mass index (BMI),43887,-0.183635243249337,0.0104375792825673,-0.204092898643169,-0.163177587855505,4.7601864021939e-69
APOA2,Apolipoprotein A-II,Physical measures,X23105.Basal metabolic rate,43885,-0.0313279582746551,0.00532135096630848,-0.0417578061686197,-0.0208981103806905,3.95598938645801e-09
APOA2,Apolipoprotein A-II,Physical measures,X23106.Impedance of whole body,43881,0.0230043386211246,0.00407276009643867,0.0150217288321048,0.0309869484101444,1.63003927142725e-08
APOA2,Apolipoprotein A-II,Physical measures,X23107.Impedance of leg (right),43884,-0.0113344614111443,0.00333406745444495,-0.0178692336218564,-0.00479968920043223,0.000675470901579656
APOA2,Apolipoprotein A-II,Physical measures,X23108.Impedance of leg (left),43883,-0.00985932017496317,0.00330539605482516,-0.0163378964424205,-0.00338074390750587,0.00285785872431866
APOA2,Apolipoprotein A-II,Physical measures,X23109.Impedance of arm (right),43876,0.0483404356445397,0.00405693863359916,0.0403888359226854,0.0562920353663941,1.10396155078403e-32
APOA2,Apolipoprotein A-II,Physical measures,X23110.Impedance of arm (left),43882,0.0491407475325233,0.0040595569934354,0.0411840158253899,0.0570974792396566,1.1252389427413e-33
APOA2,Apolipoprotein A-II,Physical measures,X23111.Leg fat percentage (right),43883,-0.0553576659286113,0.00692309436418131,-0.0689269308824067,-0.041788400974816,1.31554842026299e-15
APOA2,Apolipoprotein A-II,Physical measures,X23112.Leg fat mass (right),43882,-0.0861902887924122,0.00733484392461904,-0.100566582884666,-0.0718139947001589,7.80865983300339e-32
APOA2,Apolipoprotein A-II,Physical measures,X23113.Leg fat-free mass (right),43881,-0.00272465748218953,0.00521352527532934,-0.012943167021835,0.00749385205745597,0.60124604473221
APOA2,Apolipoprotein A-II,Physical measures,X23114.Leg predicted mass (right),43880,-0.00185892223649681,0.00524012355224559,-0.0121295643988982,0.00841171992590455,0.722780252356688
APOA2,Apolipoprotein A-II,Physical measures,X23115.Leg fat percentage (left),43877,-0.058644681848315,0.0072016146370557,-0.0727598465369441,-0.0445295171596858,3.94798666494453e-16
APOA2,Apolipoprotein A-II,Physical measures,X23116.Leg fat mass (left),43877,-0.0909266323235853,0.00764414024401998,-0.105909147201864,-0.0759441174453061,1.41123810988283e-32
APOA2,Apolipoprotein A-II,Physical measures,X23117.Leg fat-free mass (left),43874,-0.00769721067533989,0.00543814639973108,-0.0183559776188128,0.00296155626813302,0.156955210511475
APOA2,Apolipoprotein A-II,Physical measures,X23118.Leg predicted mass (left),43873,-0.00824474743000363,0.00546666911856323,-0.0189594189023876,0.0024699240423803,0.131514431888471
APOA2,Apolipoprotein A-II,Physical measures,X23119.Arm fat percentage (right),43873,-0.00084676668703691,0.00634761172207362,-0.0132880856623012,0.0115945522882274,0.893878245062334
APOA2,Apolipoprotein A-II,Physical measures,X23120.Arm fat mass (right),43871,-0.0499996826899492,0.00627816314120478,-0.0623048824467105,-0.0376944829331878,1.7046164832723e-15
APOA2,Apolipoprotein A-II,Physical measures,X23121.Arm fat-free mass (right),43871,-0.0464317357736415,0.00501139215601159,-0.0562540643994242,-0.0366094071478588,2.03181765371032e-20
APOA2,Apolipoprotein A-II,Physical measures,X23122.Arm predicted mass (right),43870,-0.0469731817726838,0.00501792580803017,-0.0568083163564229,-0.0371380471889446,8.2538070943447e-21
APOA2,Apolipoprotein A-II,Physical measures,X23123.Arm fat percentage (left),43865,0.0025114830351298,0.0065162462793055,-0.010260359672309,0.0152833257425686,0.699929114937331
APOA2,Apolipoprotein A-II,Physical measures,X23124.Arm fat mass (left),43865,-0.0468832241758985,0.00626547650564207,-0.0591635581269569,-0.03460289022484,7.41209510873044e-14
APOA2,Apolipoprotein A-II,Physical measures,X23125.Arm fat-free mass (left),43861,-0.0483914265587594,0.00510710614878989,-0.0584013546103876,-0.0383814985071312,2.78738302099089e-21
APOA2,Apolipoprotein A-II,Physical measures,X23126.Arm predicted mass (left),43858,-0.0460669787991372,0.0051253697393345,-0.0561127034882328,-0.0360212541100416,2.61470642347977e-19
APOA2,Apolipoprotein A-II,Physical measures,X23127.Trunk fat percentage,43856,-0.00847470015668342,0.00409651298885225,-0.0165038656148338,-0.000445534698533017,0.0385745084461033
APOA2,Apolipoprotein A-II,Physical measures,X23128.Trunk fat mass,43852,-0.0261877065405081,0.00450814264353118,-0.0350236661218292,-0.017351746959187,6.32882501854831e-09
APOA2,Apolipoprotein A-II,Physical measures,X23129.Trunk fat-free mass,43846,-0.032229984982413,0.00450888559262924,-0.0410674007439664,-0.0233925692208597,8.93548896190682e-13
APOA2,Apolipoprotein A-II,Physical measures,X23130.Trunk predicted mass,43841,-0.0314901172895654,0.0045153534219777,-0.0403402099966417,-0.0226400245824891,3.1238665166752e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23400.Total Cholesterol,24951,0.0217233199077293,0.00331685849400575,0.0152222772594781,0.0282243625559806,5.89064704535307e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,24951,-0.0123163519153138,0.00321019379775896,-0.0186083317589213,-0.0060243720717062,0.000125037268623644
APOA2,Apolipoprotein A-II,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",24951,-0.0323741140775231,0.00320991332834183,-0.0386655442010731,-0.0260826839539731,7.10417204728308e-24
APOA2,Apolipoprotein A-II,NMR metabolomics,X23403.VLDL Cholesterol,24951,-0.0553598390389459,0.00319649642076072,-0.061624972023637,-0.0490947060542549,8.336937123764e-67
APOA2,Apolipoprotein A-II,NMR metabolomics,X23404.Clinical LDL Cholesterol,24951,0.00324117720147248,0.00321410517814715,-0.00305846894769594,0.0095408233506409,0.313261277898206
APOA2,Apolipoprotein A-II,NMR metabolomics,X23405.LDL Cholesterol,24951,0.00672093307237529,0.0032040290746396,0.000441036086081681,0.0130008300586689,0.0359460732464319
APOA2,Apolipoprotein A-II,NMR metabolomics,X23406.HDL Cholesterol,24951,0.121485686067374,0.00366028829563987,0.11431152100792,0.128659851126828,2.06888324310885e-236
APOA2,Apolipoprotein A-II,NMR metabolomics,X23407.Total Triglycerides,24951,-0.0705431870464269,0.00337165807005293,-0.0771516368637306,-0.0639347372291232,2.2555403398063e-96
APOA2,Apolipoprotein A-II,NMR metabolomics,X23408.Triglycerides in VLDL,24951,-0.0768962706164714,0.00339044614732778,-0.0835415450652338,-0.0702509961677089,9.70177002234979e-113
APOA2,Apolipoprotein A-II,NMR metabolomics,X23409.Triglycerides in LDL,24951,-0.0374616179595595,0.00329696894266264,-0.0439236770871782,-0.0309995588319407,7.61716840646098e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23410.Triglycerides in HDL,24951,-0.0356457525778827,0.0032691065179299,-0.0420532013530254,-0.0292383038027401,1.27586972399766e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,24951,0.0189314635327462,0.00336729736812986,0.0123315606912116,0.0255313663742807,1.90607328508242e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23412.Phospholipids in VLDL,24951,-0.0688146864536892,0.00325911670648544,-0.0752025551984007,-0.0624268177089777,4.22866434446007e-98
APOA2,Apolipoprotein A-II,NMR metabolomics,X23413.Phospholipids in LDL,24951,-0.00186967150537488,0.00319736100248762,-0.00813649907025062,0.00439715605950085,0.558718035877328
APOA2,Apolipoprotein A-II,NMR metabolomics,X23414.Phospholipids in HDL,24951,0.0798272855747274,0.00356103461571868,0.0728476577279187,0.086806913421536,3.30881372515806e-110
APOA2,Apolipoprotein A-II,NMR metabolomics,X23415.Total Esterified Cholesterol,24951,0.0293983590848566,0.00333208562671614,0.0228674712564929,0.0359292469132202,1.18782261359725e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,24951,-0.0491254811496498,0.00318322789712989,-0.0553646078280244,-0.0428863544712752,1.74686893948125e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23417.Cholesteryl Esters in LDL,24951,0.0020942192321934,0.00319726517496728,-0.00417242051074247,0.00836085897512927,0.512471672715113
APOA2,Apolipoprotein A-II,NMR metabolomics,X23418.Cholesteryl Esters in HDL,24951,0.128538809829055,0.00363696517617687,0.121410358083749,0.135667261574362,5.05785508614037e-267
APOA2,Apolipoprotein A-II,NMR metabolomics,X23419.Total Free Cholesterol,24951,0.00250069168354351,0.00327787598446969,-0.00392394524601708,0.0089253286131041,0.445530235451417
APOA2,Apolipoprotein A-II,NMR metabolomics,X23420.Free Cholesterol in VLDL,24951,-0.0624864209715519,0.00323316462038892,-0.0688234236275142,-0.0561494183155896,1.28863451379146e-82
APOA2,Apolipoprotein A-II,NMR metabolomics,X23421.Free Cholesterol in LDL,24951,0.0193349839827796,0.00323431264785506,0.0129957311929837,0.0256742367725755,2.28849656764883e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23422.Free Cholesterol in HDL,24951,0.0894415723167271,0.00369292330104006,0.0822034426466886,0.0966797019867656,4.16566071442863e-128
APOA2,Apolipoprotein A-II,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,24951,-0.00615020028437551,0.00324933871783613,-0.0125189041713343,0.000218503602583298,0.0584021022233345
APOA2,Apolipoprotein A-II,NMR metabolomics,X23424.Total Lipids in VLDL,24951,-0.0730295154830174,0.00329686598586454,-0.0794913728153119,-0.0665676581507229,1.11121066742229e-107
APOA2,Apolipoprotein A-II,NMR metabolomics,X23425.Total Lipids in LDL,24951,0.00163914825240677,0.00320015182728852,-0.00463314932907873,0.00791144583389227,0.608508912674603
APOA2,Apolipoprotein A-II,NMR metabolomics,X23426.Total Lipids in HDL,24951,0.0955797230321278,0.00360091451340748,0.0885219305858491,0.102637515478406,4.1279329487861e-153
APOA2,Apolipoprotein A-II,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,24951,0.0934201234541333,0.00337961820738278,0.0867960717676631,0.100044175140604,1.08922647075975e-165
APOA2,Apolipoprotein A-II,NMR metabolomics,X23428.Concentration of VLDL Particles,24951,-0.0545966796710897,0.00322358203118411,-0.0609149004522106,-0.0482784588899689,5.50695800407154e-64
APOA2,Apolipoprotein A-II,NMR metabolomics,X23429.Concentration of LDL Particles,24951,-0.0231808635672552,0.00318477836845888,-0.0294230291694346,-0.0169386979650758,3.47169861977027e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23430.Concentration of HDL Particles,24951,0.10331666274151,0.00337806633479796,0.0966956527253055,0.109937672757714,1.04271804765434e-201
APOA2,Apolipoprotein A-II,NMR metabolomics,X23431.Average Diameter for VLDL Particles,24951,-0.0756471737889587,0.00352529324586888,-0.0825567485508617,-0.0687375990270557,3.14049784740129e-101
APOA2,Apolipoprotein A-II,NMR metabolomics,X23432.Average Diameter for LDL Particles,24951,0.0138229976583416,0.00332769291779482,0.00730071953946373,0.0203452757772194,3.27903360455627e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23433.Average Diameter for HDL Particles,24951,0.0655007012265496,0.00378496591603679,0.0580821680311175,0.0729192344219817,1.04960982726885e-66
APOA2,Apolipoprotein A-II,NMR metabolomics,X23434.Phosphoglycerides,24928,0.0295636010023435,0.00338409778193742,0.0229307693497462,0.0361964326549408,2.5632260600856e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,24928,-0.102541387687514,0.00355575784559136,-0.109510673064873,-0.0955721023101547,6.44773047986191e-180
APOA2,Apolipoprotein A-II,NMR metabolomics,X23436.Total Cholines,24928,0.0381925768230168,0.00341335076958056,0.0315024093146389,0.0448827443313947,5.4023934163797e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23437.Phosphatidylcholines,24928,0.038452982561445,0.00342392348466128,0.0317420925315089,0.0451638725913812,3.38818872326378e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23438.Sphingomyelins,24927,0.0498137428754738,0.00343166767661863,0.0430876742293013,0.0565398115216463,1.50283414814678e-47
APOA2,Apolipoprotein A-II,NMR metabolomics,X23439.Apolipoprotein B,24951,-0.0290748802182587,0.00318785471134332,-0.0353230754524916,-0.0228266849840257,8.02586516279623e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23440.Apolipoprotein A1,24951,0.100328251680773,0.00349667370571632,0.0934747712175686,0.107181732143977,3.71424457507736e-178
APOA2,Apolipoprotein A-II,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,24951,-0.0752763684773877,0.00321700200248121,-0.0815816924022509,-0.0689710445525246,8.44659528111408e-120
APOA2,Apolipoprotein A-II,NMR metabolomics,X23442.Total Fatty Acids,24928,-0.0247958059612465,0.00325093428033813,-0.0311676371507092,-0.0184239747717838,2.48303000265314e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23443.Degree of Unsaturation,24928,0.0551874244084933,0.00347572618351764,0.0483750010887988,0.0619998477281879,1.70561303996527e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23444.Omega-3 Fatty Acids,24928,-0.00941510933025105,0.0033059480845239,-0.0158947675759179,-0.00293545108458421,0.0044040584294639
APOA2,Apolipoprotein A-II,NMR metabolomics,X23445.Omega-6 Fatty Acids,24928,0.0094891030553353,0.00326131912930922,0.00309691756188922,0.0158812885487814,0.00362222674256111
APOA2,Apolipoprotein A-II,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,24928,0.0063469591188222,0.0032788843520964,-7.96542112867487e-05,0.0127735724489311,0.0529149062752414
APOA2,Apolipoprotein A-II,NMR metabolomics,X23447.Monounsaturated Fatty Acids,24928,-0.0383800921631559,0.00332054579558584,-0.0448883619225042,-0.0318718224038077,8.02664163743655e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23448.Saturated Fatty Acids,24928,-0.035581863917008,0.00326080487971826,-0.0419730414812557,-0.0291906863527602,1.16691790933695e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23449.Linoleic Acid,24928,0.00775969995767716,0.00324701856329032,0.00139554357362813,0.0141238563417262,0.0168652904490175
APOA2,Apolipoprotein A-II,NMR metabolomics,X23450.Docosahexaenoic Acid,24928,0.0390932444952633,0.00338874740628526,0.0324512995789442,0.0457351894115824,1.03745083024895e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,24928,0.00376549312553564,0.00332248736916988,-0.00274658211803732,0.0102775683691086,0.257084264404269
APOA2,Apolipoprotein A-II,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,24928,0.0682744738110608,0.00344385671060095,0.0615245146582829,0.0750244329638386,8.46561242424134e-87
APOA2,Apolipoprotein A-II,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,24928,0.0722958398731538,0.00350021263417701,0.0654354231101669,0.0791562566361408,5.43481137689159e-94
APOA2,Apolipoprotein A-II,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,24928,-0.0580793075188327,0.00358393768635467,-0.0651038253840878,-0.0510547896535775,9.22426373887652e-59
APOA2,Apolipoprotein A-II,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,24928,-0.0554453875244709,0.00323691593982444,-0.0617897427665268,-0.049101032282415,2.13480585710433e-65
APOA2,Apolipoprotein A-II,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,24928,0.058845676154545,0.00344339846695538,0.0520966151593125,0.0655947371497776,4.1842688485394e-65
APOA2,Apolipoprotein A-II,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,24928,0.0537854457568822,0.00338740248190385,0.0471461368923506,0.0604247546214137,1.7022701422726e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,24928,0.0678935527776807,0.00357216616648405,0.060892107091372,0.0748949984639894,5.57593521770523e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,24926,0.0145189397889791,0.00329070193391605,0.0080691639985036,0.0209687155794545,1.02797201758941e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23460.Alanine,24941,0.000855407430054327,0.00325134182437424,-0.00551722254571919,0.00722803740582784,0.792480562654788
APOA2,Apolipoprotein A-II,NMR metabolomics,X23461.Glutamine,24864,0.0232584952348837,0.00321829676861678,0.0169506335683948,0.0295663569013726,5.08185296037613e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23462.Glycine,24922,0.0670983457825411,0.00336814599993321,0.0604967796226721,0.0736999119424102,1.27748344595261e-87
APOA2,Apolipoprotein A-II,NMR metabolomics,X23463.Histidine,24917,-0.016432651058159,0.003193634323586,-0.0226921743323876,-0.0101731277839304,2.68919876582923e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),24931,-0.0701136081029106,0.00336510640174152,-0.076709216650324,-0.0635179995554972,1.34989639624877e-95
APOA2,Apolipoprotein A-II,NMR metabolomics,X23465.Isoleucine,24945,-0.0599547540866946,0.00328635127019459,-0.066396002576276,-0.0535135055971132,7.04676781718696e-74
APOA2,Apolipoprotein A-II,NMR metabolomics,X23466.Leucine,24946,-0.0604517342079074,0.00335623589097799,-0.0670299565542242,-0.0538735118615905,4.51392238647401e-72
APOA2,Apolipoprotein A-II,NMR metabolomics,X23467.Valine,24931,-0.0739093261915036,0.00337319995186723,-0.0805207980971634,-0.0672978542858439,2.03177755104796e-105
APOA2,Apolipoprotein A-II,NMR metabolomics,X23468.Phenylalanine,24940,-0.033850162370382,0.00321859925140767,-0.040158616903141,-0.0275417078376229,8.16599325920215e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23469.Tyrosine,24919,-0.0505541298698533,0.00328230662179582,-0.0569874508485731,-0.0441208088911335,2.79435516102691e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23470.Glucose,24905,-0.0137639639782539,0.00326575594372224,-0.0201648456279495,-0.00736308232855836,2.51065829621321e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23471.Lactate,24904,0.00332404742486982,0.00324301406046777,-0.00303226013364701,0.00968035498338664,0.305379257942233
APOA2,Apolipoprotein A-II,NMR metabolomics,X23472.Pyruvate,24863,0.000671081955202664,0.00321341064913241,-0.00562720291709685,0.00696936682750218,0.834576489777032
APOA2,Apolipoprotein A-II,NMR metabolomics,X23473.Citrate,24948,0.0185530510028825,0.00325805543705171,0.0121672623462612,0.0249388396595039,1.2511236386272e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23474.3-Hydroxybutyrate,24550,0.0444029521018874,0.00327743992425477,0.0379791698503481,0.0508267343534268,1.14901757553257e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23475.Acetate,24929,0.00328141233110868,0.00319891606836014,-0.00298846316287719,0.00955128782509454,0.305001097065872
APOA2,Apolipoprotein A-II,NMR metabolomics,X23476.Acetoacetate,24949,-0.0140996201135251,0.00322374314663143,-0.0204181566809227,-0.0077810835461275,1.22664531098603e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23477.Acetone,24949,0.0103043529445882,0.0032171302663741,0.00399877762249501,0.0166099282666815,0.00136191739827614
APOA2,Apolipoprotein A-II,NMR metabolomics,X23478.Creatinine,24333,0.0498143507505182,0.00390375416560535,0.0421629925859317,0.0574657089151047,3.57988766722352e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23479.Albumin,24947,0.0137075282885072,0.00325114507405025,0.00733528394336869,0.0200797726336457,2.49311521883124e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23480.Glycoprotein Acetyls,24951,-0.0120507432529823,0.00343204715519995,-0.0187775556771742,-0.00532393082879043,0.000446808255869844
APOA2,Apolipoprotein A-II,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,24951,-0.0937079588989769,0.00338909129957582,-0.100350577846145,-0.0870653399518082,8.86554757213302e-166
APOA2,Apolipoprotein A-II,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,24951,-0.0956663545270395,0.00337708372135268,-0.102285438620891,-0.0890472704331883,8.80212713711859e-174
APOA2,Apolipoprotein A-II,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,24951,-0.0916853061506564,0.0034072705349818,-0.0983635563992207,-0.0850070559020921,3.05682049747592e-157
APOA2,Apolipoprotein A-II,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,24951,-0.0867687409712092,0.00337642354458532,-0.0933865311185965,-0.080150950823822,9.06099288404998e-144
APOA2,Apolipoprotein A-II,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,24951,-0.0861754638093458,0.00335930019367542,-0.0927596921889497,-0.079591235429742,2.84096899964256e-143
APOA2,Apolipoprotein A-II,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,24951,-0.0852044117364096,0.00338248340542329,-0.0918340792110393,-0.07857474426178,2.77122204572431e-138
APOA2,Apolipoprotein A-II,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,24951,-0.0988398461678324,0.00335994036118424,-0.105425329275753,-0.0922543630599113,5.18640732188121e-187
APOA2,Apolipoprotein A-II,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,24951,-0.0858248192613431,0.00340814848939407,-0.0925047903005555,-0.0791448482221307,3.34554288017663e-138
APOA2,Apolipoprotein A-II,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,24951,-0.0891913688641385,0.00339905862674355,-0.0958535237725558,-0.0825292139557211,1.00203859136285e-149
APOA2,Apolipoprotein A-II,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,24951,-0.0911373745522719,0.00338000825156459,-0.0977621907253385,-0.0845125583792053,7.24440324940117e-158
APOA2,Apolipoprotein A-II,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,24951,-0.0810928676912078,0.00331746798956372,-0.0875951049507527,-0.0745906304316629,1.98894427268597e-130
APOA2,Apolipoprotein A-II,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,24951,-0.0713415644630097,0.00328027119157988,-0.0777708959985063,-0.0649122329275131,6.57514864246533e-104
APOA2,Apolipoprotein A-II,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,24951,-0.0890451289843066,0.00335328580022403,-0.0956175691527457,-0.0824726888158675,3.07337195428912e-153
APOA2,Apolipoprotein A-II,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,24951,-0.0890431569232407,0.00343146577770622,-0.0957688298475449,-0.0823174839989366,1.64364106651867e-146
APOA2,Apolipoprotein A-II,NMR metabolomics,X23495.Concentration of Large VLDL Particles,24951,-0.0774647055956307,0.00337358552591575,-0.0840769332264255,-0.0708524779648358,1.75928198366742e-115
APOA2,Apolipoprotein A-II,NMR metabolomics,X23496.Total Lipids in Large VLDL,24951,-0.0779073336549258,0.00336458420118463,-0.0845019186892476,-0.0713127486206039,2.23630192064788e-117
APOA2,Apolipoprotein A-II,NMR metabolomics,X23497.Phospholipids in Large VLDL,24951,-0.0808843898154809,0.00338274125774856,-0.087514562680668,-0.0742542169502937,6.01822119757869e-125
APOA2,Apolipoprotein A-II,NMR metabolomics,X23498.Cholesterol in Large VLDL,24951,-0.0710867027959878,0.00330861020118112,-0.0775715787903028,-0.0646018268016729,1.77672137321608e-101
APOA2,Apolipoprotein A-II,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,24951,-0.0628211749139868,0.00325523196672065,-0.0692014295687593,-0.0564409202592143,2.20612720996905e-82
APOA2,Apolipoprotein A-II,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,24951,-0.0777740261803302,0.00336849455371244,-0.0843762755056066,-0.0711717768550538,1.0093917209894e-116
APOA2,Apolipoprotein A-II,NMR metabolomics,X23501.Triglycerides in Large VLDL,24951,-0.0775038004377975,0.00337666465893466,-0.0841220631693095,-0.0708855377062856,2.17223777422814e-115
APOA2,Apolipoprotein A-II,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,24951,-0.0420823201843686,0.00320060559381308,-0.0483555071482422,-0.035809133220495,2.35526917657222e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23503.Total Lipids in Medium VLDL,24951,-0.0481831264630756,0.00322300613188755,-0.0545002184815752,-0.041866034444576,2.58342529631687e-50
APOA2,Apolipoprotein A-II,NMR metabolomics,X23504.Phospholipids in Medium VLDL,24951,-0.042084334924401,0.0031941304079561,-0.0483448305239949,-0.035823839324807,1.64538527326111e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23505.Cholesterol in Medium VLDL,24951,-0.0189264143394622,0.00319792612660295,-0.025194349547604,-0.0126584791313204,3.29456337858956e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,24951,-0.00522593907242281,0.00323262378874145,-0.011561881698356,0.00111000355351043,0.105971992052618
APOA2,Apolipoprotein A-II,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,24951,-0.0343194111298188,0.00318643650405446,-0.0405648266777655,-0.028073995581872,5.4415885425174e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23508.Triglycerides in Medium VLDL,24951,-0.0593483184699115,0.00333264885831057,-0.0658803102322002,-0.0528163267076228,1.67085243264377e-70
APOA2,Apolipoprotein A-II,NMR metabolomics,X23509.Concentration of Small VLDL Particles,24951,-0.0440362401419406,0.00326681262808163,-0.0504391928929806,-0.0376332873909006,2.86631177225652e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23510.Total Lipids in Small VLDL,24951,-0.0438695692698113,0.00325532425665754,-0.0502500048128601,-0.0374891337267625,3.00966822134504e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23511.Phospholipids in Small VLDL,24951,-0.0347377980467449,0.0032058582974406,-0.0410212803097285,-0.0284543157837614,2.68173191397353e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23512.Cholesterol in Small VLDL,24951,-0.0352616461231246,0.00319630449910937,-0.041526402941379,-0.0289968893048703,3.11307858645772e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,24951,-0.0406989106027158,0.00320656600145866,-0.0469837799655748,-0.0344140412398568,8.47338655864423e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,24951,-0.0250906500959153,0.00318761908395369,-0.0313383835004645,-0.018842916691366,3.65222630847587e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23515.Triglycerides in Small VLDL,24951,-0.0463196546414313,0.00335469636915226,-0.0528948595249697,-0.0397444497578929,3.3170563076818e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,24951,-0.0483770111719995,0.00322339502198788,-0.0546948654150957,-0.0420591569289032,1.08234382704415e-50
APOA2,Apolipoprotein A-II,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,24951,-0.0514495164533071,0.00323083063477756,-0.0577819444974711,-0.0451170884091431,8.16293612575539e-57
APOA2,Apolipoprotein A-II,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,24951,-0.0590612897410837,0.00321823124263345,-0.0653690229766453,-0.0527535565055222,9.86946227858149e-75
APOA2,Apolipoprotein A-II,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,24951,-0.039998558847063,0.00328139905132335,-0.0464301009876568,-0.0335670167064693,4.42190386603207e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,24951,-0.0360048873894471,0.00331006052535358,-0.0424926060191402,-0.0295171687597541,1.70278899922129e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,24951,-0.0475908683471904,0.00323221289987964,-0.0539260056309545,-0.0412557310634264,7.26168959178405e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,24951,-0.0473407695660941,0.0033034582238242,-0.0538155476847896,-0.0408659914473987,2.15215301261425e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23523.Concentration of IDL Particles,24951,-0.0317112362599092,0.00322851935053046,-0.0380391341869489,-0.0253833383328695,9.93309122379582e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23524.Total Lipids in IDL,24951,-0.00691950962243494,0.00332173841827019,-0.0134301169222445,-0.000408902322625378,0.0372523721616861
APOA2,Apolipoprotein A-II,NMR metabolomics,X23525.Phospholipids in IDL,24951,-0.0109755210600925,0.0033225941854513,-0.017487805663577,-0.00446323645660793,0.000956890323001438
APOA2,Apolipoprotein A-II,NMR metabolomics,X23526.Cholesterol in IDL,24951,0.000329196109115267,0.00333632467887711,-0.00621000026148386,0.0068683924797144,0.921400855389034
APOA2,Apolipoprotein A-II,NMR metabolomics,X23527.Cholesteryl Esters in IDL,24951,-0.00135341977214823,0.00333651296151951,-0.00789298517672646,0.00518614563243001,0.685011350888111
APOA2,Apolipoprotein A-II,NMR metabolomics,X23528.Free Cholesterol in IDL,24951,0.00501187657550237,0.00332842968990002,-0.00151184561670167,0.0115355987677064,0.132136809883996
APOA2,Apolipoprotein A-II,NMR metabolomics,X23529.Triglycerides in IDL,24951,-0.045567352801328,0.00327705227604141,-0.0519903752623692,-0.0391443303402868,8.6110314550142e-44
APOA2,Apolipoprotein A-II,NMR metabolomics,X23530.Concentration of Large LDL Particles,24951,-0.0212595835909441,0.00319258417443914,-0.0275170485728448,-0.0150021186090434,2.81327237624995e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23531.Total Lipids in Large LDL,24951,0.0100657066310689,0.00322542134651668,0.00374388079189618,0.0163875324702416,0.00180602111375045
APOA2,Apolipoprotein A-II,NMR metabolomics,X23532.Phospholipids in Large LDL,24951,0.00544847050396682,0.00322159224342243,-0.000865850293141147,0.0117627913010748,0.0908043683192317
APOA2,Apolipoprotein A-II,NMR metabolomics,X23533.Cholesterol in Large LDL,24951,0.0153803898436188,0.00323232661655097,0.00904502967517892,0.0217157500120587,1.96320095869176e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,24951,0.0131014880559049,0.00322104104516578,0.00678824760737999,0.0194147285044299,4.76723336953366e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23535.Free Cholesterol in Large LDL,24951,0.0215432904673094,0.00326883186877133,0.0151363800045176,0.0279502009301013,4.47042928040091e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23536.Triglycerides in Large LDL,24951,-0.035095420889843,0.00328493569718382,-0.0415338948563233,-0.0286569469233627,1.38457027428528e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23537.Concentration of Medium LDL Particles,24951,-0.0214336399423015,0.00318493770121306,-0.0276761178366791,-0.0151911620479239,1.73710291558387e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23538.Total Lipids in Medium LDL,24951,-0.00843305231753953,0.00318806011040745,-0.0146816501339381,-0.00218445450114093,0.0081694148907463
APOA2,Apolipoprotein A-II,NMR metabolomics,X23539.Phospholipids in Medium LDL,24951,-0.00688167829229137,0.00318461162217421,-0.0131235170717528,-0.000639839512829915,0.0307113164898839
APOA2,Apolipoprotein A-II,NMR metabolomics,X23540.Cholesterol in Medium LDL,24951,-0.00607697325102785,0.00318572579597821,-0.0123209958111451,0.000167049309089438,0.0564591724656522
APOA2,Apolipoprotein A-II,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,24951,-0.0146216876756544,0.003192832304264,-0.0208796389920118,-0.00836373635929696,4.68262156142598e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,24951,0.0174335010913198,0.00319122635730128,0.0111786974310093,0.0236883047516303,4.72769606920923e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23543.Triglycerides in Medium LDL,24951,-0.0330269282503744,0.00331629650790513,-0.0395268694058685,-0.0265269870948804,2.54733873131422e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23544.Concentration of Small LDL Particles,24951,-0.0313500998704446,0.00318110285239558,-0.0375850614611399,-0.0251151382797493,7.17319043019747e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23545.Total Lipids in Small LDL,24951,-0.0204050789757606,0.00318390132589462,-0.026645525574514,-0.0141646323770071,1.49261542311552e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23546.Phospholipids in Small LDL,24951,-0.0211809209002354,0.00318314182840833,-0.0274198788839157,-0.0149419629165551,2.90959512422633e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23547.Cholesterol in Small LDL,24951,-0.0139945117381414,0.0031822891898146,-0.020231798550178,-0.00775722492610479,1.09895015057102e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,24951,-0.0225332289957068,0.00318766394749161,-0.0287810503327903,-0.0162854076586232,1.60296418843723e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23549.Free Cholesterol in Small LDL,24951,0.00989613801119512,0.00319111317610389,0.0036415561860315,0.0161507198363587,0.00192982027350743
APOA2,Apolipoprotein A-II,NMR metabolomics,X23550.Triglycerides in Small LDL,24951,-0.0531200007930422,0.00333807984917776,-0.0596626372974306,-0.0465773642886538,9.74650877130561e-57
APOA2,Apolipoprotein A-II,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,24951,0.0346678633228067,0.00374105545440321,0.0273353946321764,0.042000332013437,2.06721214482984e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23552.Total Lipids in Very Large HDL,24951,0.0277186633371219,0.00375596605838871,0.0203569698626801,0.0350803568115638,1.63356351588433e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23553.Phospholipids in Very Large HDL,24951,0.0232546753600266,0.00374335181772448,0.0159177057972866,0.0305916449227665,5.30532857406146e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23554.Cholesterol in Very Large HDL,24951,0.0390323400589149,0.00376423198992989,0.0316544453586523,0.0464102347591775,3.84864341641825e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,24951,0.0537491755304427,0.00380107934587023,0.0462990600125371,0.0611992910483484,3.19732646763478e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,24951,-0.00837511384704578,0.00357450218898425,-0.0153811381374549,-0.00136908955663666,0.0191364071311668
APOA2,Apolipoprotein A-II,NMR metabolomics,X23557.Triglycerides in Very Large HDL,24951,-0.023781567344827,0.00323552258872049,-0.0301231916187191,-0.0174399430709348,2.04077807163909e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23558.Concentration of Large HDL Particles,24951,0.0986822782619546,0.00383404765325833,0.0911675448615683,0.106197011662341,3.32202429189729e-144
APOA2,Apolipoprotein A-II,NMR metabolomics,X23559.Total Lipids in Large HDL,24951,0.0905739428765448,0.00381317316572774,0.0831001234717184,0.0980477622813712,2.40499459847187e-123
APOA2,Apolipoprotein A-II,NMR metabolomics,X23560.Phospholipids in Large HDL,24951,0.0840094293192023,0.00377184035272405,0.0766166222278632,0.0914022364105415,7.81968892292264e-109
APOA2,Apolipoprotein A-II,NMR metabolomics,X23561.Cholesterol in Large HDL,24951,0.0988965851599129,0.00383472051201531,0.0913805329563629,0.106412637363463,9.13437510513435e-145
APOA2,Apolipoprotein A-II,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,24951,0.106340503371489,0.00382674604822971,0.0988400811169586,0.113840925626019,2.10733139129353e-167
APOA2,Apolipoprotein A-II,NMR metabolomics,X23563.Free Cholesterol in Large HDL,24951,0.0723816452828076,0.00383300634602699,0.0648689528445947,0.0798943377210205,5.52165792195074e-79
APOA2,Apolipoprotein A-II,NMR metabolomics,X23564.Triglycerides in Large HDL,24951,0.00454472948625171,0.00330363365692973,-0.00193039248133057,0.011019851453834,0.168934325844766
APOA2,Apolipoprotein A-II,NMR metabolomics,X23565.Concentration of Medium HDL Particles,24951,0.0988156709555003,0.0034625385517143,0.0920290953941403,0.10560224651686,2.65993902474249e-176
APOA2,Apolipoprotein A-II,NMR metabolomics,X23566.Total Lipids in Medium HDL,24951,0.0860459456739522,0.00343036725894492,0.0793224258464201,0.0927694655014842,3.76923519529356e-137
APOA2,Apolipoprotein A-II,NMR metabolomics,X23567.Phospholipids in Medium HDL,24951,0.0685598942212911,0.00340385580623078,0.0618883368410788,0.0752314516015034,1.63677686839955e-89
APOA2,Apolipoprotein A-II,NMR metabolomics,X23568.Cholesterol in Medium HDL,24951,0.112633234557435,0.0034737440469118,0.105824696225488,0.119441772889383,6.1411421647972e-226
APOA2,Apolipoprotein A-II,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,24951,0.11607012807379,0.00345622809930933,0.109295920999143,0.122844335148436,7.25409927030031e-242
APOA2,Apolipoprotein A-II,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,24951,0.094461435918156,0.00352767204138196,0.0875471987170473,0.101375673119265,9.47845075844337e-156
APOA2,Apolipoprotein A-II,NMR metabolomics,X23571.Triglycerides in Medium HDL,24951,-0.0402184976466031,0.00326812693658027,-0.0466240264423004,-0.0338129688509058,1.05676131730531e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23572.Concentration of Small HDL Particles,24951,0.0641841711990058,0.00317229613577792,0.057966470772881,0.0704018716251305,2.67966957470813e-90
APOA2,Apolipoprotein A-II,NMR metabolomics,X23573.Total Lipids in Small HDL,24951,0.0447116658794557,0.00320895333171517,0.038422117349294,0.0510012144096175,5.80301949276515e-44
APOA2,Apolipoprotein A-II,NMR metabolomics,X23574.Phospholipids in Small HDL,24951,0.0377312698961221,0.00322771878925584,0.0314049410691806,0.0440575987230635,1.7374251182222e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23575.Cholesterol in Small HDL,24951,0.073245126654759,0.00316554283592256,0.0670406626963508,0.0794495906131672,3.27937385964522e-117
APOA2,Apolipoprotein A-II,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,24951,0.0751612816850863,0.0031506328347804,0.0689860413289167,0.0813365220412559,2.17697015622913e-124
APOA2,Apolipoprotein A-II,NMR metabolomics,X23577.Free Cholesterol in Small HDL,24951,0.0582003685580132,0.00323725055209758,0.051855357475902,0.0645453796401245,8.1881542071042e-72
APOA2,Apolipoprotein A-II,NMR metabolomics,X23578.Triglycerides in Small HDL,24951,-0.0599708823343615,0.00341558072871129,-0.0666654205626357,-0.0532763441060874,1.33660854750506e-68
APOA2,Apolipoprotein A-II,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23872,0.0311441682382322,0.00326081839392896,0.0247529641861314,0.037535372290333,1.40350891595058e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23872,0.0619897757667084,0.00327651325410535,0.0555678097886619,0.0684117417447548,3.00329354463097e-79
APOA2,Apolipoprotein A-II,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23872,0.0447283626394305,0.00325462787190717,0.0383492920104925,0.0511074332683686,8.1686435670675e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23872,0.0780528955813065,0.00329826994274957,0.0715882864935173,0.0845175046690957,2.13804733068799e-122
APOA2,Apolipoprotein A-II,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23872,-0.0564186059335255,0.00323553266109449,-0.0627602499492707,-0.0500769619177803,1.13271860154408e-67
APOA2,Apolipoprotein A-II,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,24683,-0.0487696305820404,0.00316617386359794,-0.0549753313546924,-0.0425639298093885,2.75319487483513e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,24683,0.0519929163485711,0.00346728097046211,0.0451970456464654,0.0587887870506768,1.31739941036156e-50
APOA2,Apolipoprotein A-II,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,24683,0.0595673449750578,0.00345883918045253,0.0527880201813708,0.0663466697687447,4.44111541864276e-66
APOA2,Apolipoprotein A-II,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,24683,0.0118373023034184,0.00337040572101912,0.00523130709022095,0.0184432975166159,0.000445325228652633
APOA2,Apolipoprotein A-II,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,24683,-0.0290445361679171,0.00339047722990774,-0.0356898715385363,-0.022399200797298,1.12812254275047e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,24946,-0.0604725419052398,0.00336675602349605,-0.067071383711292,-0.0538737000991875,1.10177900626297e-71
APOA2,Apolipoprotein A-II,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,24946,0.0253809000867691,0.00327005377718333,0.0189715946834898,0.0317902054900485,8.70611633285555e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,24946,0.0378365460255265,0.00338628114139362,0.031199434988395,0.044473657062658,6.44114107638949e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,24946,-0.0061748093716328,0.00320544800412071,-0.0124574874597094,0.000107868716443785,0.0540722504396432
APOA2,Apolipoprotein A-II,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,24946,0.00429864954741574,0.00317284841735778,-0.00192013335060551,0.010517432445437,0.175486078480028
APOA2,Apolipoprotein A-II,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,24951,0.00953208964878604,0.00335775339399656,0.00295089299655279,0.0161132863010193,0.00453159225687339
APOA2,Apolipoprotein A-II,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,24951,0.0400453940748941,0.00349763489873387,0.0331900296733758,0.0469007584764125,2.82255906605825e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,24951,0.0441836612275462,0.00352054693385537,0.0372833892371897,0.0510839332179027,5.09368526673129e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,24951,0.0278200621798967,0.00341912257729822,0.0211185819283922,0.0345215424314013,4.25291295062957e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,24951,-0.0335287785166981,0.00347115226864362,-0.0403322369632396,-0.0267253200701566,4.90832892190999e-22
APOA2,Apolipoprotein A-II,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,24951,0.0291557783339488,0.00341334137806771,0.0224656292329361,0.0358459274349615,1.39685517201672e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,24951,0.00620362240837279,0.00331299568262475,-0.00028984912957172,0.0126970939463173,0.0611475691837885
APOA2,Apolipoprotein A-II,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,24951,-0.0116526919459156,0.0032311348867404,-0.0179857163239268,-0.00531966756790439,0.000311107436947086
APOA2,Apolipoprotein A-II,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,24951,0.0318064694697254,0.00343259353043145,0.0250785861500798,0.0385343527893711,2.08369170649041e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,24951,-0.013225537051645,0.00334571708209811,-0.0197831425325573,-0.00666793157073267,7.73982265345514e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,24951,-0.0755561708194727,0.00330237214960799,-0.0820288202327043,-0.069083521406241,1.1317437770653e-114
APOA2,Apolipoprotein A-II,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,24951,0.020476672305401,0.00348705663328799,0.0136420413041565,0.0273113033066454,4.35515385545379e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,24951,0.0222696914434047,0.00352106179865983,0.0153684103180314,0.029170972568778,2.58013113520772e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,24951,0.00226467264503827,0.00323200577647021,-0.00407005867684334,0.00859940396691988,0.483495596805965
APOA2,Apolipoprotein A-II,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,24951,-0.00321963035036236,0.00346490375473745,-0.0100108417096478,0.00357158100892305,0.35278819374437
APOA2,Apolipoprotein A-II,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,24951,-0.0209289851211682,0.00318515092168962,-0.0271718809276798,-0.0146860893146565,5.10327838155711e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,24951,0.0367493965610573,0.0033509174412935,0.030181598376122,0.0433171947459925,6.38112045748701e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,24951,0.0221385489886428,0.00333545699033605,0.0156010532875841,0.0286760446897014,3.25955594252466e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,24951,0.046644768157429,0.00324051492894965,0.0402933588966877,0.0529961774181703,8.66327451449657e-47
APOA2,Apolipoprotein A-II,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,24951,-0.0375818606324986,0.00341824491597686,-0.0442816206678133,-0.030882100597184,4.71195477628123e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,24951,-0.0346420967743249,0.00320067414134827,-0.0409154180913675,-0.0283687754572823,3.0669826278774e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,24951,0.0723118620334062,0.00338128756385292,0.0656845384082545,0.0789391856585579,1.44827085333967e-100
APOA2,Apolipoprotein A-II,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,24951,0.0410161635907645,0.00317166962521627,0.0347996911253406,0.0472326360561884,3.93719058432425e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,24951,0.0505252205375566,0.00350379769423553,0.043657777056855,0.0573926640182583,5.97436179756021e-47
APOA2,Apolipoprotein A-II,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,24951,-0.0475489108584781,0.00335683355679444,-0.0541283046297952,-0.040969517087161,2.26904923464608e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,24951,0.0148375138440317,0.00320877095349721,0.00854832277517717,0.0211267049128862,3.78208150866416e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,24951,0.0228873028650701,0.00323748650382413,0.0165418293175748,0.0292327764125654,1.59627040284149e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,24951,-0.0542659524361414,0.00325395109511539,-0.0606436965825675,-0.0478882082897152,4.18699897204643e-62
APOA2,Apolipoprotein A-II,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,24951,0.0811429808146626,0.00345111240486622,0.0743788005011248,0.0879071611282004,6.34677194625987e-121
APOA2,Apolipoprotein A-II,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,24951,-0.028677568626385,0.00329397803279468,-0.0351337655706625,-0.0222213716821074,3.33738572773336e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,24951,0.00325251795252047,0.00322783391292727,-0.00307403651681699,0.00957907242185792,0.313633616109589
APOA2,Apolipoprotein A-II,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,24951,0.0395254123225793,0.00320386198539335,0.0332458428312083,0.0458049818139503,7.25436159390328e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,24951,-0.0237632138516609,0.0032245710579996,-0.0300833731253401,-0.0174430545779816,1.76699705748777e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,24951,0.0649048825702485,0.00334267691894071,0.0583532358091247,0.0714565293313723,2.2879321212468e-83
APOA2,Apolipoprotein A-II,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,24951,-0.0443071137188245,0.00336769168413655,-0.0509077894197321,-0.0377064380179169,2.11235044591281e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,24937,0.00111527061300367,0.00359335525630357,-0.00592770568935133,0.00815824691535868,0.756282000903831
APOA2,Apolipoprotein A-II,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,24937,0.031792789361616,0.0033488634917704,0.0252290169177461,0.038356561805486,2.42512278115765e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,24937,0.0941967383768271,0.0031730366462575,0.0879775865501624,0.100415890203492,2.35149684175468e-190
APOA2,Apolipoprotein A-II,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,24937,-0.0861991726107118,0.00375687789625224,-0.0935626532873662,-0.0788356919340575,2.62877304529653e-115
APOA2,Apolipoprotein A-II,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,24937,-0.0390926505856247,0.00354755805698649,-0.0460458643773182,-0.0321394367939312,3.57143854632896e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,24951,-0.0769203233178167,0.00350625973589177,-0.0837925924001645,-0.0700480542354688,1.12711771779122e-105
APOA2,Apolipoprotein A-II,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,24951,0.0883702933426639,0.00359146264393117,0.0813310265605588,0.095409560124769,4.13735141602345e-132
APOA2,Apolipoprotein A-II,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,24951,0.103197402855069,0.0035148386315075,0.0963083191373138,0.110086486572823,2.59710026332225e-186
APOA2,Apolipoprotein A-II,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,24951,-0.0323253732405138,0.00350044242503284,-0.0391862403935781,-0.0254645060874494,2.79148445578476e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,24951,-0.06717751304793,0.00347840506725216,-0.0739951869797443,-0.0603598391161158,1.68241953568091e-82
APOA2,Apolipoprotein A-II,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,24951,-0.166097882752369,0.00342448160534672,-0.172809866698848,-0.159385898805889,0
APOA2,Apolipoprotein A-II,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,24951,0.130616012286011,0.00342576985142366,0.12390150337722,0.137330521194801,1.75213324067354e-308
APOA2,Apolipoprotein A-II,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,24951,0.119849360379382,0.00333751551583983,0.113307829968336,0.126390890790428,2.20430122722952e-275
APOA2,Apolipoprotein A-II,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,24951,0.0942791927390122,0.00371116924651594,0.0870053010158409,0.101553084462183,1.39274873053795e-140
APOA2,Apolipoprotein A-II,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,24951,-0.0964388934643047,0.00338695437109185,-0.103077324031645,-0.0898004628969647,1.59807604263812e-175
APOA2,Apolipoprotein A-II,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,24951,-0.0399007727485199,0.00325743272054284,-0.0462853408807839,-0.0335162046162559,2.13201474875819e-34
APOA2,Apolipoprotein A-II,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,24951,0.0846871853801411,0.00322940072587805,0.0783575599574201,0.0910168108028621,1.51664518604178e-149
APOA2,Apolipoprotein A-II,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,24951,0.0727238335653197,0.00321790687582692,0.066416736088699,0.0790309310419405,5.81294749112987e-112
APOA2,Apolipoprotein A-II,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,24951,0.039600997619667,0.00342250255638772,0.0328928926091471,0.046309102630187,6.95089420772052e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,24951,-0.0962581626798588,0.00344773254817443,-0.103015718474281,-0.0895006068854369,6.17466522726065e-169
APOA2,Apolipoprotein A-II,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,44150,0.00104144668155424,0.00273489629896128,-0.00431895006440988,0.00640184342751836,0.703353988311938
APOA2,Apolipoprotein A-II,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,44150,0.00213209682282648,0.00267354917535557,-0.00310805956087044,0.00737225320652341,0.425177727398593
APOA2,Apolipoprotein A-II,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,41022,0.00226726134586498,0.00255480405290071,-0.00274015459782042,0.00727467728955037,0.374841775939139
APOA2,Apolipoprotein A-II,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,41022,0.000211352720429744,0.00278959005610117,-0.00525624378952856,0.00567894923038804,0.939606594213342
APOA2,Apolipoprotein A-II,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,41022,0.00108059402303141,0.00273892574497667,-0.00428770043712285,0.00644888848318567,0.693190312154571
APOA2,Apolipoprotein A-II,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,41022,-0.0011135280511075,0.00252159999322934,-0.006055864037837,0.003828807935622,0.658784027864586
APOA2,Apolipoprotein A-II,Working and living environment,X24009.Traffic intensity on the nearest road,44150,0.0185403875934096,0.0390099643942296,-0.0579191426192804,0.0949999178060996,0.634594665694286
APOA2,Apolipoprotein A-II,Working and living environment,X24010.Inverse distance to the nearest road,44150,0.00174461905133676,0.00239865688846605,-0.0029567484500567,0.00644598655273022,0.467026677376315
APOA2,Apolipoprotein A-II,Working and living environment,X24011.Traffic intensity on the nearest major road,44150,-0.00391508979174811,0.00239116342055788,-0.00860177009604156,0.000771590512545339,0.101571617816254
APOA2,Apolipoprotein A-II,Working and living environment,X24012.Inverse distance to the nearest major road,44150,0.000371659310772292,0.00244082541825279,-0.00441235850900317,0.00515567713054776,0.878976353893811
APOA2,Apolipoprotein A-II,Working and living environment,X24013.Total traffic load on major roads,44150,0.0342871552419682,0.0271899973162102,-0.0190052394978039,0.0875795499817403,0.207307978190669
APOA2,Apolipoprotein A-II,Working and living environment,X24015.Sum of road length of major roads within 100m,44150,0.0435782509458497,0.0264302366081652,-0.00822501280615413,0.0953815146978534,0.0991951365315189
APOA2,Apolipoprotein A-II,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,44150,0.00400014058171425,0.00273627930172497,-0.0013629668496667,0.0093632480130952,0.143778351881115
APOA2,Apolipoprotein A-II,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,44150,0.00306853788441517,0.00273336480185754,-0.0022888571272256,0.00842593289605595,0.261603797794211
APOA2,Apolipoprotein A-II,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,44150,0.00329073322545368,0.0027042129725784,-0.00200952420079998,0.00859099065170734,0.223652085103201
APOA2,Apolipoprotein A-II,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,44053,0.0011121916876976,0.00264857021696101,-0.00407900593754599,0.00630338931294119,0.67454481928766
APOA2,Apolipoprotein A-II,Working and living environment,X24020.Average daytime sound level of noise pollution,44150,-0.00122596395005095,0.00240450286562225,-0.00593878956667057,0.00348686166656866,0.610150896257555
APOA2,Apolipoprotein A-II,Working and living environment,X24021.Average evening sound level of noise pollution,44150,-0.00120201430719815,0.00240472194858679,-0.00591526932642826,0.00351124071203197,0.617179081205595
APOA2,Apolipoprotein A-II,Working and living environment,X24022.Average night-time sound level of noise pollution,44150,-0.00123474157342177,0.00240448062607691,-0.00594752360053252,0.00347804045368899,0.607592323079024
APOA2,Apolipoprotein A-II,Working and living environment,X24023.Average 16-hour sound level of noise pollution,44150,-0.00118799936554522,0.00240463409755253,-0.00590108219674818,0.00352508346565775,0.621276296222652
APOA2,Apolipoprotein A-II,Working and living environment,X24024.Average 24-hour sound level of noise pollution,44150,-0.00119167507941967,0.0024046929832852,-0.00590487332665866,0.00352152316781932,0.62020575548405
APOA2,Apolipoprotein A-II,Health and medical history,X2405.Number of children fathered,20268,-0.114844904547065,0.0294043251254567,-0.17247738179296,-0.0572124273011696,9.42521255332744e-05
APOA2,Apolipoprotein A-II,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",39119,-0.00199164390370611,0.00281680226187716,-0.00751257633698534,0.00352928852957313,0.479534354801786
APOA2,Apolipoprotein A-II,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",39119,0.00285250023010236,0.00255288870432516,-0.00215116163037495,0.00785616209057968,0.263846540821714
APOA2,Apolipoprotein A-II,Working and living environment,"X24502.Water percentage, buffer 1000m",39119,-0.00144915113984074,0.00253191560167606,-0.00641170571912583,0.00351340343944434,0.567085699357967
APOA2,Apolipoprotein A-II,Working and living environment,"X24503.Greenspace percentage, buffer 300m",39119,-0.0011458846951416,0.00264828994905779,-0.00633653299529488,0.00404476360501168,0.665243447114601
APOA2,Apolipoprotein A-II,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",39119,0.000224687708872087,0.00257792301333493,-0.00482804139726438,0.00527741681500855,0.930546032084154
APOA2,Apolipoprotein A-II,Working and living environment,"X24505.Water percentage, buffer 300m",39119,0.0022370734601569,0.00255227055630516,-0.00276537683020122,0.00723952375051502,0.380761889705203
APOA2,Apolipoprotein A-II,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",44370,-0.000303409880327671,0.00268558319079516,-0.00556715293428619,0.00496033317363084,0.910049080196664
APOA2,Apolipoprotein A-II,Working and living environment,"X24507.Natural environment percentage, buffer 300m",44370,-0.00230433857353112,0.00252730594952955,-0.00725785823460904,0.0026491810875468,0.361891255301054
APOA2,Apolipoprotein A-II,Working and living environment,X24508.Distance (Euclidean) to coast,44370,0.00280258704981778,0.00239830264066496,-0.00189808612588554,0.0075032602255211,0.242582775704225
APOA2,Apolipoprotein A-II,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,9839,0.0130391350285293,0.0401053046959463,-0.0655672621755255,0.0916455322325841,0.745095319164789
APOA2,Apolipoprotein A-II,Health and medical history,X2704.Years since last cervical smear test,18392,0.0514507756683691,0.0293347036502979,-0.00604524348621478,0.108946794822953,0.0794605777934947
APOA2,Apolipoprotein A-II,Health and medical history,X2714.Age when periods started (menarche),23434,0.00363825812549004,0.0248124379513305,-0.0449941202591177,0.0522706365100978,0.88342500589091
APOA2,Apolipoprotein A-II,Health and medical history,X2734.Number of live births,24167,-0.0754352929652966,0.0239331976816881,-0.122344360421405,-0.0285262255091879,0.00162404369255793
APOA2,Apolipoprotein A-II,Health and medical history,X2744.Birth weight of first child,19198,-0.00968512657245705,0.0266967548240948,-0.0620107660276828,0.0426405128827687,0.716771052884037
APOA2,Apolipoprotein A-II,Health and medical history,X2754.Age at first live birth,16332,-0.00236713975318797,0.00408420650447929,-0.0103721845019674,0.00563790499559143,0.562203349586322
APOA2,Apolipoprotein A-II,Health and medical history,X2764.Age at last live birth,16283,-0.00774672753496955,0.00392268580355559,-0.0154351917099385,-5.82633600005955e-05,0.0483017201673809
APOA2,Apolipoprotein A-II,Health and medical history,X2794.Age started oral contraceptive pill,18519,0.00365656312730553,0.00441548604888358,-0.0049977895285063,0.0123109157831173,0.40761183562482
APOA2,Apolipoprotein A-II,Health and medical history,X2804.Age when last used oral contraceptive pill,16795,-0.00975209473827958,0.00383321504961734,-0.0172651962355296,-0.0022389932410296,0.0109647548986005
APOA2,Apolipoprotein A-II,Lifestyle factors,X2867.Age started smoking in former smokers,10976,0.00193990872162998,0.00503772401121641,-0.00793403034035419,0.0118138477836141,0.700188269455351
APOA2,Apolipoprotein A-II,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",16646,0.0247524332703443,0.0361553785962993,-0.0461121087784023,0.0956169753190909,0.49359785825547
APOA2,Apolipoprotein A-II,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,16641,-0.00728900976410158,0.0397300671021608,-0.0851599412843367,0.0705819217561336,0.854436738953749
APOA2,Apolipoprotein A-II,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,16670,-0.053590255861031,0.0410474901350556,-0.13404333652574,0.0268628248036781,0.191717822997177
APOA2,Apolipoprotein A-II,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",16618,-0.0326482235156805,0.0402019590725553,-0.111444063297889,0.0461476162665278,0.416742863483554
APOA2,Apolipoprotein A-II,Mental health,X28739.Difficulty with standing for long periods,16688,0.0637963954464937,0.0348727352603632,-0.00455416566381818,0.132146956556806,0.0673566418590355
APOA2,Apolipoprotein A-II,Mental health,X28740.Difficulty with taking care of household responsibilities,16728,-0.0321401744221274,0.0385317558302962,-0.107662415849508,0.0433820670052531,0.40422432014936
APOA2,Apolipoprotein A-II,Mental health,X28741.Difficulty learning a new task,16591,0.0130346480019762,0.0442094584331848,-0.073615890527066,0.0996851865310184,0.768120988725219
APOA2,Apolipoprotein A-II,Mental health,X28742.Difficulty with joining in community activities,15983,0.0991931430723258,0.0442438267670859,0.0124752426088374,0.185911043535814,0.0249772629079031
APOA2,Apolipoprotein A-II,Mental health,X28743.Difficulty with being emotionally affected by health problems,16619,-0.00914679238639833,0.0376106746337908,-0.0828637146686283,0.0645701298958316,0.807856018881102
APOA2,Apolipoprotein A-II,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,16725,0.00967689339122108,0.0531239584618739,-0.0944460651940518,0.113799851976494,0.855461838211932
APOA2,Apolipoprotein A-II,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,10437,0.065200086578726,0.0377066372514893,-0.00870492243419292,0.139105095591645,0.0838135027099356
APOA2,Apolipoprotein A-II,Lifestyle factors,X2897.Age stopped smoking,10974,-0.000908980481861742,0.00523561996575826,-0.0111707956147479,0.00935283465102444,0.862171501017304
APOA2,Apolipoprotein A-II,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,14904,0.0149322646635649,0.00846705470864138,-0.00166316256537223,0.031527691892502,0.0778244901858847
APOA2,Apolipoprotein A-II,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,14904,-0.0203122166051286,0.00919821063844312,-0.0383407094564771,-0.00228372375378007,0.0272400010986584
APOA2,Apolipoprotein A-II,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,14904,0.0157180254733621,0.0308363117914915,-0.0447211456379614,0.0761571965846855,0.610251998329247
APOA2,Apolipoprotein A-II,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,14904,0.0245236433330962,0.032606820033536,-0.0393857239326343,0.0884330105988268,0.452001816722011
APOA2,Apolipoprotein A-II,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,14904,0.00203137061429678,0.0347818457618887,-0.0661410470790051,0.0702037883075987,0.953428260600376
APOA2,Apolipoprotein A-II,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,14904,0.00407084046829704,0.02960663743936,-0.0539581689128486,0.0620998498494426,0.890639378760279
APOA2,Apolipoprotein A-II,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,14904,-0.0124561719617834,0.0133832291727096,-0.0386873011402943,0.0137749572167275,0.352008372274194
APOA2,Apolipoprotein A-II,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,14904,-0.0260531267662609,0.0239174577880671,-0.0729313440308724,0.0208250904983506,0.276042190811779
APOA2,Apolipoprotein A-II,Mental health,X29002.Recent lack of interest or pleasure in doing things,14817,-0.0203004720418932,0.0415880416209241,-0.101813033618904,0.061212089535118,0.625463268805329
APOA2,Apolipoprotein A-II,Mental health,X29003.Recent feelings of depression,14804,-0.0197575526011152,0.0403800947811301,-0.0989025383721302,0.0593874331698998,0.62464407706879
APOA2,Apolipoprotein A-II,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",14825,-0.00663735065522455,0.0325668936737355,-0.0704684622557461,0.057193760945297,0.838507368683492
APOA2,Apolipoprotein A-II,Mental health,X29005.Recent feelings of tiredness or low energy,14833,-0.0296715287844645,0.0328371125218554,-0.0940322693273011,0.0346892117583721,0.366223622001728
APOA2,Apolipoprotein A-II,Mental health,X29006.Recent poor appetite or overeating,14845,0.0359382736724908,0.0450835948481157,-0.052425572229816,0.124302119574798,0.425378151470556
APOA2,Apolipoprotein A-II,Mental health,X29007.Recent feelings of inadequacy,14782,0.0424791083827986,0.043827571201607,-0.0434229311723511,0.128381147937948,0.33244505159416
APOA2,Apolipoprotein A-II,Mental health,X29008.Recent trouble concentrating on things,14841,-0.0567014871304648,0.0435931913068918,-0.142144142091973,0.0287411678310432,0.193382768512628
APOA2,Apolipoprotein A-II,Mental health,X29009.Recent changes in speed or amount of moving or speaking,14825,0.0265812776548028,0.0761237292758809,-0.122621231725924,0.175783787035529,0.726955260673243
APOA2,Apolipoprotein A-II,Mental health,X29010.Recent thoughts of suicide or self-harm,14751,0.106789573397013,0.0828741102867896,-0.0556436827650948,0.26922282955912,0.19756583068342
APOA2,Apolipoprotein A-II,Mental health,X29038#0.Substances taken for depression_None of options listed,13988,-0.021656161238011,0.0166861136252371,-0.0543609439434758,0.0110486214674537,0.194358479936012
APOA2,Apolipoprotein A-II,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),13988,0.0274045609470189,0.0316139905872415,-0.0345588606039744,0.0893679824980122,0.386039550588992
APOA2,Apolipoprotein A-II,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),13988,-0.0201735498406038,0.0166718338390525,-0.0528503441651468,0.0125032444839391,0.226284840660826
APOA2,Apolipoprotein A-II,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),13988,0.0523131667788797,0.0496302131709126,-0.0449620510361089,0.149588384593868,0.291874186331047
APOA2,Apolipoprotein A-II,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),13988,-0.0185777751321109,0.0313801738094893,-0.0800829157987099,0.0429273655344881,0.553844967805367
APOA2,Apolipoprotein A-II,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),13988,0.00637284299721691,0.0337862572582448,-0.0598482212289429,0.0725939072233767,0.850391559240029
APOA2,Apolipoprotein A-II,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),13988,-0.0480462814129956,0.0386219937517029,-0.123745389166333,0.0276528263403421,0.213515463020062
APOA2,Apolipoprotein A-II,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),13988,0.0147393954314704,0.0425652346037305,-0.0686884643918412,0.0981672552547821,0.729139170684745
APOA2,Apolipoprotein A-II,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),13988,0.0356275275582571,0.0320722162800901,-0.0272340163507195,0.0984890714672337,0.266650609264631
APOA2,Apolipoprotein A-II,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,13988,-0.0173265181483089,0.0163516032751616,-0.0493756605676257,0.0147226242710079,0.289334927079018
APOA2,Apolipoprotein A-II,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,13988,-0.0223046987670347,0.0253899376304593,-0.0720689765227349,0.0274595789886655,0.379695264243312
APOA2,Apolipoprotein A-II,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,13988,-0.0843997884761799,0.0398330856492039,-0.16247263634862,-0.00632694060374024,0.0341218952722403
APOA2,Apolipoprotein A-II,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,13988,-0.128015281093387,0.0503488904862919,-0.226699106446519,-0.0293314557402545,0.0110149358519428
APOA2,Apolipoprotein A-II,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,13988,-0.0291777898478351,0.0330843027392487,-0.0940230232167626,0.0356674435210923,0.377833906644977
APOA2,Apolipoprotein A-II,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,13988,0.00988665892971711,0.0522357656317957,-0.0924954417086024,0.112268759568037,0.849884022160039
APOA2,Apolipoprotein A-II,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,13988,-0.0801130631929842,0.0489255517529239,-0.176007144628715,0.0157810182427467,0.10155934223124
APOA2,Apolipoprotein A-II,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,13988,-0.0438592633243365,0.0273632758028767,-0.0974912838979748,0.00977275724930181,0.108990079803898
APOA2,Apolipoprotein A-II,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,13988,-0.0278669269396913,0.0267257595405631,-0.0802494156391949,0.0245155617598123,0.297105686646414
APOA2,Apolipoprotein A-II,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,13988,-0.0657829929890562,0.0383389262946507,-0.140927288526571,0.00936130254845913,0.0862157423404758
APOA2,Apolipoprotein A-II,Mental health,X29058.Recent feelings or nervousness or anxiety,14601,0.014831503128115,0.0382442438873331,-0.0601272148910578,0.0897902211472879,0.698162247913072
APOA2,Apolipoprotein A-II,Mental health,X29059.Recent inability to stop or control worrying,14619,0.0208830592997682,0.0395258595247819,-0.0565876253688044,0.0983537439683408,0.597271987345874
APOA2,Apolipoprotein A-II,Mental health,X29060.Recent worrying too much about different things,14609,0.0245875642400532,0.0365435420434654,-0.047037778165139,0.0962129066452454,0.50106657629758
APOA2,Apolipoprotein A-II,Mental health,X29061.Recent trouble relaxing,14613,-0.00822938742094617,0.03875861039836,-0.0841962638017318,0.0677374889598395,0.831857152536143
APOA2,Apolipoprotein A-II,Mental health,X29062.Recent restlessness,14628,-0.0225046111817286,0.0547454731501232,-0.12980573855597,0.0847965161925128,0.681022018235013
APOA2,Apolipoprotein A-II,Mental health,X29063.Recent easy annoyance or irritability,14585,-0.0107939039189609,0.0392543787370518,-0.0877324862435824,0.0661446784056607,0.783340692499307
APOA2,Apolipoprotein A-II,Mental health,X29064.Recent feelings of foreboding,14581,0.02990501581102,0.0446669813177591,-0.0576422675717878,0.117452299193828,0.503180457577731
APOA2,Apolipoprotein A-II,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,13988,-0.0352956790955628,0.0176344091811806,-0.0698591210906767,-0.00073223710044891,0.0453553345567215
APOA2,Apolipoprotein A-II,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,13988,-0.048248527828841,0.0291687088676537,-0.105419197209442,0.00892214155176022,0.0981257104959795
APOA2,Apolipoprotein A-II,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',13988,6.63122985619349e-05,0.0380272627453021,-0.0744671226822301,0.074599747279354,0.998608666992714
APOA2,Apolipoprotein A-II,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,13988,-0.00441913416209638,0.0402055678043649,-0.0832220470586516,0.0743837787344589,0.912479564449721
APOA2,Apolipoprotein A-II,Mental health,X29065#2.Symptoms of panic attack_Sweating,13988,-0.0214956098052094,0.0266348961909008,-0.073700006339375,0.0307087867289562,0.41965321161881
APOA2,Apolipoprotein A-II,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,13988,-0.00783089670358392,0.0288563532361141,-0.0643893490463675,0.0487275556391996,0.786106534116547
APOA2,Apolipoprotein A-II,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,13988,-0.0105190994789853,0.0288993781823123,-0.0671618807163175,0.0461236817583468,0.715870600919777
APOA2,Apolipoprotein A-II,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,13988,-0.024347188714059,0.0269374135873671,-0.0771445193452984,0.0284501419171805,0.366094316588278
APOA2,Apolipoprotein A-II,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,13988,-0.0255148997958623,0.0352812437739377,-0.0946661375927801,0.0436363380010555,0.469577753713803
APOA2,Apolipoprotein A-II,Mental health,X29076.Felt loved as a child,14559,0.0217603732545373,0.0339123276343915,-0.04470778890887,0.0882285354179445,0.521100458411013
APOA2,Apolipoprotein A-II,Mental health,X29077.Physically abused by family as a child,14584,0.0237275470885039,0.0455236453341536,-0.0654987977664371,0.112953891943445,0.602225842858814
APOA2,Apolipoprotein A-II,Mental health,X29078.Felt hated by family member as a child,14557,0.0152706526883409,0.0459414846859268,-0.0747746572960757,0.105315962672757,0.739596908155885
APOA2,Apolipoprotein A-II,Mental health,X29079.Sexually molested as a child,14451,0.0390807389861056,0.0617474878472419,-0.0819443371944886,0.1601058151667,0.526801000587361
APOA2,Apolipoprotein A-II,Mental health,X29080.Someone to take to doctor when needed as a child,14534,-0.00910564605644743,0.0491483219307176,-0.105436357040654,0.0872250649277591,0.853020869528988
APOA2,Apolipoprotein A-II,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,14556,0.15392656815919,0.0646873614158183,0.0271393397841861,0.280713796534194,0.0173467884982424
APOA2,Apolipoprotein A-II,Mental health,X29082.Belittlement by partner or ex-partner as an adult,14475,-0.0158934085904538,0.0502866578246127,-0.114455257926695,0.0826684407457871,0.751964434011991
APOA2,Apolipoprotein A-II,Mental health,X29083.Physical violence by partner or ex-partner as an adult,14568,-0.0292100922802675,0.0561450724569401,-0.13925443429587,0.0808342497353352,0.60288957928445
APOA2,Apolipoprotein A-II,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,14524,-0.0621102125071348,0.0791167325626662,-0.217179008329961,0.092958583315691,0.432439875773244
APOA2,Apolipoprotein A-II,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,14525,0.0542685138462676,0.075300301180714,-0.0933200764679319,0.201857104160467,0.471109099740446
APOA2,Apolipoprotein A-II,Mental health,X29086.Experienced a violent or sexual assault,14573,0.138416550289527,0.0632498114876211,0.0144469197737902,0.262386180805265,0.0286555500673757
APOA2,Apolipoprotein A-II,Mental health,X29087.Experienced a life-threatening injury or illness,14578,0.0222405293853055,0.0394798301465069,-0.0551399377018481,0.0996209964724591,0.573212716105632
APOA2,Apolipoprotein A-II,Mental health,X29088.Experienced a marital separation or divorce,14581,-0.0206965246368158,0.037167081155959,-0.0935440037024955,0.0521509544288639,0.57763782159807
APOA2,Apolipoprotein A-II,Mental health,X29089.Experienced the death of a spouse or partner,14598,0.000705404296221061,0.0497727255306018,-0.0968491377437586,0.0982599463362007,0.988692547970855
APOA2,Apolipoprotein A-II,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,14574,0.00407446427819146,0.0466347718539792,-0.0873296885556079,0.0954786171119908,0.930378884524339
APOA2,Apolipoprotein A-II,Lifestyle factors,X29091.Frequency of drinking alcohol,14579,0.104897344897434,0.0310072876964022,0.0441230610124855,0.165671628782382,0.000718900906249291
APOA2,Apolipoprotein A-II,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,12971,0.114685071075459,0.0355579740719202,0.0449914418944949,0.184378700256422,0.00126153733524626
APOA2,Apolipoprotein A-II,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,13005,0.167895675923128,0.0361317065859023,0.0970775310147593,0.238713820831496,3.40489276635302e-06
APOA2,Apolipoprotein A-II,Mental health,X29104.Ever used cannabis,14571,0.0986720390854456,0.0443919023897156,0.0116639104016031,0.185680167769288,0.0262480607629829
APOA2,Apolipoprotein A-II,Mental health,X29108.Ever thought that life not worth living,14505,0.0285080924435203,0.0385846791434678,-0.0471178786776767,0.104134063564717,0.460013166223545
APOA2,Apolipoprotein A-II,Mental health,X29109.Ever contemplated self-harm,14536,0.0401351225767979,0.0523302019335635,-0.0624320732129866,0.142702318366582,0.443118325055546
APOA2,Apolipoprotein A-II,Mental health,X29111.Ever self-harmed,14562,0.0662275037508278,0.0843434366835648,-0.0990856321489592,0.231540639650615,0.432341893878874
APOA2,Apolipoprotein A-II,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,14556,0.00709717326096762,0.054776341717764,-0.10026445650585,0.114458803027785,0.896911282143914
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,15088,-0.042704808266474,0.0373230255240641,-0.11585793829364,0.0304483217606916,0.252561065985446
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,15088,-0.0656209587939239,0.0292038190522875,-0.122860444136407,-0.00838147345144034,0.0246544843635474
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,15088,-0.0497155541755665,0.0310023805078567,-0.110480219970966,0.0110491116198327,0.108822228171395
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,15088,-0.0487403611477676,0.0421009582815807,-0.131258239379666,0.0337775170841305,0.247004034338566
APOA2,Apolipoprotein A-II,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,14540,0.0616888931840343,0.0347760184118533,-0.00647210290319807,0.129849889271267,0.0761019986580496
APOA2,Apolipoprotein A-II,Health and medical history,X29153.Pain or discomfort today,14562,0.0200548316151699,0.0327699877808555,-0.044174344435307,0.0842840076656468,0.5405554178197
APOA2,Apolipoprotein A-II,Mental health,X29154.Anxiety or depression today,14562,-0.0423754842809408,0.0408887796217407,-0.122517492339552,0.0377665237776709,0.300051582823265
APOA2,Apolipoprotein A-II,Mental health,X29166.Frequency of confiding in someone close,14194,-0.0374953876823993,0.0320309275502227,-0.100276005680836,0.0252852303160372,0.241779477200501
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,14519,0.00501934792767968,0.00859907191640251,-0.0118348330284692,0.0218735288838286,0.55942579309472
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,14519,0.00818108848791584,0.00864455189635148,-0.00876223322893307,0.0251244102047647,0.343967178318704
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,14519,-0.00501107404522266,0.0108117573318582,-0.0262021184156648,0.0161799703252195,0.643024600222748
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,14519,-0.024211375488205,0.0115521973769953,-0.0468536823471159,-0.00156906862929419,0.0361150704127512
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,14519,-0.0284886433763261,0.0185942713579022,-0.0649334152378143,0.00795612848516219,0.125514788428536
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,14519,-0.00625496383310894,0.00886160122779348,-0.0236237022395842,0.0111137745733663,0.480292577296934
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,14514,-0.00314813506730727,0.00960713951665819,-0.0219781285199573,0.0156818583853428,0.743153037789582
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,14514,-0.00529020368723569,0.0140419934884569,-0.0328125109246111,0.0222321035501397,0.706371125915493
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,14514,-0.00471240188672596,0.0218549783980475,-0.0475481595468991,0.0381233557734472,0.82928587592363
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,14514,0.00135336984419951,0.0194511345441345,-0.0367708538623041,0.0394775935507031,0.944530556314615
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,14514,-0.0297407232538914,0.0287424998548067,-0.0860760229693125,0.0265945764615296,0.300812336823386
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,14514,0.00498287785970253,0.0136806453123114,-0.0218311869524279,0.0317969426718329,0.715692864653652
APOA2,Apolipoprotein A-II,Mental health,X29171.Frequency of feeling 'in tune' with people,14269,0.00873457867958048,0.0397032637453222,-0.0690838182612509,0.0865529756204119,0.825877038488125
APOA2,Apolipoprotein A-II,Mental health,X29172.Freuency of feeling that lacks companionship,14455,0.021391553324279,0.0361563371381531,-0.0494748674665011,0.0922579741150592,0.554100610602494
APOA2,Apolipoprotein A-II,Mental health,X29173.Frequency of feeling left out,14375,-0.0563409022317234,0.0376857191773741,-0.130204911819377,0.0175231073559299,0.134931208055985
APOA2,Apolipoprotein A-II,Mental health,X29174.Frequency of feeling isolated from others,14431,-0.037996499636486,0.0388648337900359,-0.114171573864956,0.0381785745919843,0.328260110598465
APOA2,Apolipoprotein A-II,Mental health,X29175.Tendency to bounce back quickly after hard times,14543,0.112519044575525,0.0323072362213954,0.0491968615815895,0.17584122756946,0.000497693282929766
APOA2,Apolipoprotein A-II,Mental health,X29176.Ability to make it through stressful events,14543,-0.0547597690843086,0.0312603621395307,-0.116030078877789,0.00651054070917152,0.0798410450786485
APOA2,Apolipoprotein A-II,Mental health,X29177.Quick recovery from stressful events,14543,0.0812558785216142,0.0319626509581645,0.0186090826436117,0.143902674399617,0.01102558373004
APOA2,Apolipoprotein A-II,Mental health,X29178.Hard to snap back when something bad happens,14543,-0.0734876841346471,0.031521828174134,-0.13527046735595,-0.0117049009133446,0.0197497377145121
APOA2,Apolipoprotein A-II,Mental health,X29179.Comes through difficult times with little trouble,14543,0.087183409737366,0.0318790864874067,0.0247004002220489,0.149666419252683,0.00624910010728776
APOA2,Apolipoprotein A-II,Mental health,X29180.Tendency to take a long time to get over setbacks,14543,-0.0605181405731037,0.0316911348018303,-0.122632764784691,0.0015964836384838,0.0562013650019585
APOA2,Apolipoprotein A-II,Mental health,X29181.General happiness,14461,-0.0783639700794123,0.0329919963039036,-0.143028282835063,-0.0136996573237613,0.0175504323451813
APOA2,Apolipoprotein A-II,Mental health,X29182.Belief that own life is meaningful,14290,0.0474670384229177,0.0329262001262103,-0.0170683138244545,0.11200239067029,0.149431801486261
APOA2,Apolipoprotein A-II,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,9992,-0.00218217468188746,0.0358049844655511,-0.0723599442343676,0.0679955948705927,0.951403344385161
APOA2,Apolipoprotein A-II,Health and medical history,X2946.Father's age,9711,0.00864089314974735,0.00752727879299925,-0.00611257328453118,0.0233943595840259,0.251020076600964
APOA2,Apolipoprotein A-II,Health and medical history,X2966.Age high blood pressure diagnosed,11117,-0.0282941645758692,0.0063317320424032,-0.0407043593789795,-0.015883969772759,7.9501602096785e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30000.White blood cell (leukocyte) count,43340,-0.0320150217899001,0.00254304820776982,-0.036999396277129,-0.0270306473026713,2.80177745418442e-36
APOA2,Apolipoprotein A-II,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,43341,-0.0428644054183216,0.00285409347896244,-0.048458428637088,-0.0372703821995552,7.45417192942494e-51
APOA2,Apolipoprotein A-II,Blood and urine assays,X30020.Haemoglobin concentration,43341,-0.060418656982793,0.00305433474408158,-0.0664051530811929,-0.0544321608843931,1.04329371424034e-86
APOA2,Apolipoprotein A-II,Blood and urine assays,X30030.Haematocrit percentage,43341,-0.0444953909631701,0.00299141643711341,-0.0503585671799124,-0.0386322147464278,6.42476619686433e-50
APOA2,Apolipoprotein A-II,Blood and urine assays,X30040.Mean corpuscular volume,43341,0.00883570932353951,0.00251364866128521,0.0039089579474205,0.0137624606996585,0.000440048244657538
APOA2,Apolipoprotein A-II,Blood and urine assays,X30050.Mean corpuscular haemoglobin,43340,-0.00776694205736516,0.00251958473203761,-0.0127053281321589,-0.00282855598257145,0.00205310387906957
APOA2,Apolipoprotein A-II,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,43340,-0.0325895668215847,0.00246014658676352,-0.0374114541316412,-0.0277676795115282,5.61766953213846e-40
APOA2,Apolipoprotein A-II,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,43341,0.0424122354232362,0.0024482146634032,0.0376137346829659,0.0472107361635065,5.2424462888798e-67
APOA2,Apolipoprotein A-II,Blood and urine assays,X30080.Platelet count,43341,0.010688377560738,0.00251541277585875,0.00575816852005483,0.0156185866014211,2.15026702199773e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30090.Platelet crit,43341,0.0114677688552808,0.00257325719079914,0.00642418476131443,0.0165113529492471,8.35098685967828e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,43341,-0.00187168102664722,0.00241229649835936,-0.00659978216343156,0.00285642011013712,0.437817120895521
APOA2,Apolipoprotein A-II,Blood and urine assays,X30110.Platelet distribution width,43341,-0.00965417061026575,0.002445994982797,-0.0144483207765479,-0.00486002044398362,7.92845870771856e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30120.Lymphocyte count,43274,-0.0572603112000251,0.00248941628639796,-0.0621395671213651,-0.0523810552786851,2.25408444560643e-116
APOA2,Apolipoprotein A-II,Blood and urine assays,X30130.Monocyte count,43274,-0.0291531756823987,0.00253097886995258,-0.0341138942675058,-0.0241924570972917,1.17950430605127e-30
APOA2,Apolipoprotein A-II,Blood and urine assays,X30140.Neutrophill count,43274,-0.0118405724798421,0.00252157565292795,-0.0167828607595808,-0.00689828420010328,2.66504328366925e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30150.Eosinophill count,43274,-0.00895666305860317,0.00245043908044623,-0.0137595236562778,-0.00415380246092857,0.000257359965772899
APOA2,Apolipoprotein A-II,Blood and urine assays,X30160.Basophill count,43274,-0.0931124772787938,0.01960535965021,-0.131538982193205,-0.0546859723643823,2.04736957069062e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30170.Nucleated red blood cell count,43274,0.154148669001798,0.0917045527848586,-0.025592254456525,0.333889592460121,0.0927842923811278
APOA2,Apolipoprotein A-II,Blood and urine assays,X30180.Lymphocyte percentage,43275,-0.033675531732615,0.00246272564778187,-0.0385024740022674,-0.0288485894629625,1.77756683838339e-42
APOA2,Apolipoprotein A-II,Blood and urine assays,X30190.Monocyte percentage,43275,-0.00666760079200707,0.00250597751960492,-0.0115793167304327,-0.00175588485358143,0.0078012123974633
APOA2,Apolipoprotein A-II,Blood and urine assays,X30200.Neutrophill percentage,43275,0.028671091320056,0.00244091083488207,0.0238869060836872,0.0334552765564249,8.27019610154046e-32
APOA2,Apolipoprotein A-II,Blood and urine assays,X30210.Eosinophill percentage,43275,0.00125659150359045,0.00242545375125973,-0.00349729784887863,0.00601048085605952,0.604401529455251
APOA2,Apolipoprotein A-II,Blood and urine assays,X30220.Basophill percentage,43275,-0.00146885098492339,0.00242091658127399,-0.00621384748422042,0.00327614551437363,0.544031026777329
APOA2,Apolipoprotein A-II,Blood and urine assays,X30230.Nucleated red blood cell percentage,43274,0.156962001786902,0.0920757206355327,-0.0235064106587426,0.337430414232546,0.0882565148513002
APOA2,Apolipoprotein A-II,Blood and urine assays,X30240.Reticulocyte percentage,42550,-0.0162937162874184,0.00260904784488038,-0.021407450063384,-0.0111799825114529,4.27574571878523e-10
APOA2,Apolipoprotein A-II,Blood and urine assays,X30250.Reticulocyte count,42550,-0.025235361138458,0.00266656504044781,-0.0304618286177357,-0.0200088936591803,3.12124286551912e-21
APOA2,Apolipoprotein A-II,Blood and urine assays,X30260.Mean reticulocyte volume,42550,0.0399020303523173,0.00247697279101455,0.0350471636819288,0.0447568970227058,3.27113923978945e-58
APOA2,Apolipoprotein A-II,Blood and urine assays,X30270.Mean sphered cell volume,42550,0.0195991155752267,0.00250440990996146,0.0146904721517022,0.0245077589987511,5.15868870474e-15
APOA2,Apolipoprotein A-II,Blood and urine assays,X30280.Immature reticulocyte fraction,42550,0.0110825791029045,0.00260870314822037,0.00596952093239253,0.0161956372734164,2.15846961377339e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30290.High light scatter reticulocyte percentage,42550,-0.008082592761942,0.00266493922610621,-0.0133058736451102,-0.00285931187877382,0.00242332085869812
APOA2,Apolipoprotein A-II,Blood and urine assays,X30300.High light scatter reticulocyte count,42550,-0.0153411051634751,0.00270597277448025,-0.0206448118014563,-0.0100373985254938,1.44267110310911e-08
APOA2,Apolipoprotein A-II,Blood and urine assays,X30500.Microalbumin in urine,14064,0.0391546019366482,0.00448827569436051,0.0303575815757017,0.0479516222975948,2.99040193077763e-18
APOA2,Apolipoprotein A-II,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,43427,-0.0190684318716673,0.00262490061642655,-0.0242132370798633,-0.0139236266634712,3.80868278382015e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30520.Potassium in urine,43345,-0.0124527963869942,0.0024418256705128,-0.0172387747011993,-0.0076668180727891,3.41461797090502e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30530.Sodium in urine,43326,-0.020399892144282,0.00255429974772772,-0.0254063196498283,-0.0153934646387357,1.42233255200113e-15
APOA2,Apolipoprotein A-II,Blood and urine assays,X30600.Albumin,39027,0.0101893568341631,0.00263218324166442,0.0050302776805008,0.0153484359878253,0.000108536536258856
APOA2,Apolipoprotein A-II,Blood and urine assays,X30610.Alkaline phosphatase,42590,-0.0303736467647076,0.00253034793928388,-0.035333128725704,-0.0254141648037112,3.84152624138207e-33
APOA2,Apolipoprotein A-II,Blood and urine assays,X30620.Alanine aminotransferase,42583,-0.0288735225583003,0.00267515439916056,-0.034116825180655,-0.0236302199359456,4.01816843575195e-27
APOA2,Apolipoprotein A-II,Blood and urine assays,X30630.Apolipoprotein A,38768,0.169987952308374,0.00275805025732962,0.164582173804008,0.17539373081274,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30640.Apolipoprotein B,42351,-0.0350774869353152,0.00244153143934931,-0.0398628885564399,-0.0302920853141906,1.07382313139534e-46
APOA2,Apolipoprotein A-II,Blood and urine assays,X30650.Aspartate aminotransferase,42457,0.0135201247252783,0.00253853489702596,0.00854459632710741,0.0184956531234492,1.00933650580081e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30660.Direct bilirubin,36094,0.0435274798289138,0.00272895211271021,0.0381787336880018,0.0488762259698258,4.44943694706295e-57
APOA2,Apolipoprotein A-II,Blood and urine assays,X30670.Urea,42576,0.0131682339104515,0.00260819214745906,0.00805617730143175,0.0182802905194713,4.46430801353229e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30680.Calcium,39022,0.0256716747723468,0.0025555780940117,0.0206627417080839,0.0306806078366098,1.0292104148567e-23
APOA2,Apolipoprotein A-II,Blood and urine assays,X30690.Cholesterol,42601,-0.00033601321313446,0.00249085237043771,-0.00521808385919237,0.00454605743292345,0.892692456852285
APOA2,Apolipoprotein A-II,Blood and urine assays,X30700.Creatinine,42588,0.0862972234668116,0.00303638706010924,0.0803459048289975,0.0922485421046257,4.93600897592853e-176
APOA2,Apolipoprotein A-II,Blood and urine assays,X30710.C-reactive protein,42465,-0.0454620917038605,0.00272523223949003,-0.050803546893261,-0.0401206365144601,2.80333862931023e-62
APOA2,Apolipoprotein A-II,Blood and urine assays,X30720.Cystatin C,42605,0.116755027621276,0.00284884377632352,0.111171293819682,0.12233876142287,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30730.Gamma glutamyltransferase,42585,0.00980596043830449,0.0027333789798717,0.00444853763775595,0.015163383238853,0.000334255089910155
APOA2,Apolipoprotein A-II,Blood and urine assays,X30740.Glucose,38976,-0.0127671389856097,0.00263382047862621,-0.0179294271237171,-0.00760485084750235,1.25581244776725e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),42426,-0.00902871130183967,0.00265180289647923,-0.014226244978939,-0.00383117762474039,0.000662872889036774
APOA2,Apolipoprotein A-II,Blood and urine assays,X30760.HDL cholesterol,38997,0.173778345799777,0.00288941066340209,0.168115100899509,0.179441590700045,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30770.IGF-1,42381,-0.0252640518702548,0.00256680254655744,-0.0302949848615074,-0.0202331188790022,7.80498798956368e-23
APOA2,Apolipoprotein A-II,Blood and urine assays,X30780.LDL direct,42505,-0.0284538228414577,0.00245178981838658,-0.0332593308854954,-0.02364831479742,4.31397718536871e-31
APOA2,Apolipoprotein A-II,Blood and urine assays,X30790.Lipoprotein A,34072,-0.00666607322963661,0.00272180806696694,-0.0120008170408918,-0.0013313294183814,0.0143250106694989
APOA2,Apolipoprotein A-II,Blood and urine assays,X30810.Phosphate,38940,0.019725489303121,0.00264840260999329,0.0145346201875342,0.0249163584187079,9.66722521548663e-14
APOA2,Apolipoprotein A-II,Blood and urine assays,X30830.SHBG,38658,0.109311366577164,0.00299202757290413,0.103446992534272,0.115175740620057,2.52576381504763e-287
APOA2,Apolipoprotein A-II,Blood and urine assays,X30840.Total bilirubin,42432,0.0406665311053755,0.00259748193351325,0.0355754665156896,0.0457575956950615,4.30511705879984e-55
APOA2,Apolipoprotein A-II,Blood and urine assays,X30850.Testosterone,38447,0.0376620785264807,0.00424740111109649,0.0293371723487315,0.0459869847042298,7.82397050954699e-19
APOA2,Apolipoprotein A-II,Blood and urine assays,X30860.Total protein,38996,0.0105819137049343,0.00259877725934406,0.00548831027661999,0.0156755171332487,4.67268547897226e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30870.Triglycerides,42572,-0.0850127965328634,0.00262900879947391,-0.0901656537798323,-0.0798599392858945,1.20943558040178e-226
APOA2,Apolipoprotein A-II,Blood and urine assays,X30880.Urate,42541,0.0172304960575752,0.00309036095880893,0.0111733885783097,0.0232876035368407,2.48227948341491e-08
APOA2,Apolipoprotein A-II,Blood and urine assays,X30890.Vitamin D,40670,0.0195694420487154,0.00276099754916339,0.0141578868523551,0.0249809972450756,1.38458995763037e-12
APOA2,Apolipoprotein A-II,Physical measures,X3137.Number of measurements made,40476,0.00815180582552244,0.0227153166131614,-0.0363702147362739,0.0526738263873188,0.719695528131082
APOA2,Apolipoprotein A-II,Physical measures,X3143.Ankle spacing width,25207,0.00143188595666318,0.00437083459156685,-0.00713494984280784,0.0099987217561342,0.743216749883409
APOA2,Apolipoprotein A-II,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",25206,-0.0161774577336311,0.00336264182070221,-0.0227682357022074,-0.00958667976505471,1.51092916445125e-06
APOA2,Apolipoprotein A-II,Physical measures,X3146.Speed of sound through heel,25207,-0.010728442911518,0.00325746142286301,-0.0171130673003295,-0.00434381852270652,0.000990853613080645
APOA2,Apolipoprotein A-II,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",25207,-0.012982650162093,0.00328921224407775,-0.0194295061604853,-0.00653579416370056,7.93382820861102e-05
APOA2,Apolipoprotein A-II,Physical measures,X3148.Heel bone mineral density (BMD),25186,-0.0123236143252359,0.00329605506543153,-0.0187838822534817,-0.00586334639699013,0.000185237762151346
APOA2,Apolipoprotein A-II,Health and medical history,X3526.Mother's age at death,26667,-0.00496786842138378,0.00322800051853168,-0.0112947494377059,0.00135901259493831,0.123818010941109
APOA2,Apolipoprotein A-II,Health and medical history,X3581.Age at menopause (last menstrual period),13850,-0.00966629621481349,0.00429656105268569,-0.0180875558780774,-0.00124503655154954,0.0244788730576233
APOA2,Apolipoprotein A-II,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",8801,-0.00516180139965588,0.00557916929430233,-0.0160969732164884,0.00577337041717668,0.354891581759892
APOA2,Apolipoprotein A-II,Physical measures,X4100.Ankle spacing width (left),14552,0.00486028866077766,0.00579223657836662,-0.00649249503282091,0.0162130723543762,0.401424770128586
APOA2,Apolipoprotein A-II,Physical measures,X4101.Heel broadband ultrasound attenuation (left),14550,-0.0121764009794764,0.00444342365226006,-0.0208855113379061,-0.0034672906210467,0.00614543883758039
APOA2,Apolipoprotein A-II,Physical measures,X4103.Speed of sound through heel (left),14552,-0.00960348101112476,0.00430364946944936,-0.0180386339712455,-0.00116832805100401,0.0256649454903875
APOA2,Apolipoprotein A-II,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",14552,-0.0107698802763809,0.00434774167904147,-0.0192914539673022,-0.00224830658545964,0.0132559983620623
APOA2,Apolipoprotein A-II,Physical measures,X4105.Heel bone mineral density (BMD) (left),14542,-0.0108445482357793,0.00435277022682984,-0.0193759778803658,-0.00231311859119281,0.0127346816955573
APOA2,Apolipoprotein A-II,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",14552,-0.0107610742995393,0.00434776190594906,-0.0192826876351995,-0.00223946096387914,0.0133318125475828
APOA2,Apolipoprotein A-II,Physical measures,X4119.Ankle spacing width (right),14541,0.00420201715612576,0.00571545478714779,-0.0070002742266839,0.0154043085389354,0.462227991214043
APOA2,Apolipoprotein A-II,Physical measures,X4120.Heel broadband ultrasound attenuation (right),14540,-0.0174485334430022,0.00446144185625767,-0.0261929594812672,-0.00870410740473716,9.23470958660312e-05
APOA2,Apolipoprotein A-II,Physical measures,X4122.Speed of sound through heel (right),14541,-0.0129070911838637,0.00430495995236917,-0.0213448126905072,-0.00446936967722009,0.00272047148926218
APOA2,Apolipoprotein A-II,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",14541,-0.0149391594910007,0.00435489041221442,-0.023474744698941,-0.00640357428306043,0.000604294586613318
APOA2,Apolipoprotein A-II,Physical measures,X4124.Heel bone mineral density (BMD) (right),14529,-0.015391795924801,0.00435836390467252,-0.0239341891779592,-0.00684940267164288,0.000414407373927616
APOA2,Apolipoprotein A-II,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",14541,-0.014940041070601,0.004354899919884,-0.0234756449135736,-0.00640443722762836,0.000603860879283477
APOA2,Apolipoprotein A-II,Physical measures,X4194.Pulse rate,15129,-0.0308077747233245,0.00416956308253685,-0.0389801183650967,-0.0226354310815523,1.55989041555189e-13
APOA2,Apolipoprotein A-II,Physical measures,X4195.Pulse wave reflection index,15129,-0.00183324784679662,0.00426186973890795,-0.0101865125350562,0.00652001684146296,0.66709188171715
APOA2,Apolipoprotein A-II,Physical measures,X4196.Pulse wave peak to peak time,15119,0.0148542340981038,0.00424505904975293,0.00653391836058803,0.0231745498356195,0.000468031780496026
APOA2,Apolipoprotein A-II,Physical measures,X4198.Position of the pulse wave peak,15129,-0.0127637616613217,0.00428074737854198,-0.021154026523264,-0.00437349679937942,0.00287140867282287
APOA2,Apolipoprotein A-II,Physical measures,X4199.Position of pulse wave notch,15129,-0.020296092108177,0.00415107506927889,-0.0284321992439636,-0.0121599849723903,1.02204600252557e-06
APOA2,Apolipoprotein A-II,Physical measures,X4200.Position of the shoulder on the pulse waveform,15129,-0.0177092258540068,0.00429984819295348,-0.0261369283121956,-0.00928152339581796,3.83258595524977e-05
APOA2,Apolipoprotein A-II,Physical measures,X4269.Number of triplets attempted (left),14834,-0.0641350676282805,0.0952075071452625,-0.250741781632995,0.122471646376434,0.500554187910891
APOA2,Apolipoprotein A-II,Physical measures,X4270.Volume level set by participant (left),14672,0.0117840106662107,0.0303690287114281,-0.0477392856081883,0.0713073069406098,0.69800150456582
APOA2,Apolipoprotein A-II,Physical measures,X4276.Number of triplets attempted (right),14841,-0.00955418728175714,0.0939493454663581,-0.193694904395819,0.174586529832305,0.91900007472167
APOA2,Apolipoprotein A-II,Physical measures,X4277.Volume level set by participant (right),14668,-0.00913212397665361,0.0301802208880237,-0.06828535691718,0.0500211089638728,0.762209386143496
APOA2,Apolipoprotein A-II,Cognitive function,X4288.Time to answer,15157,-0.00292368720337762,0.00485627247931345,-0.012441981262832,0.00659460685607674,0.547154206404456
APOA2,Apolipoprotein A-II,Cognitive function,X4290.Duration screen displayed,15157,0.00226793967873245,0.00436433145538285,-0.00628614997381794,0.0108220293312828,0.603312767494407
APOA2,Apolipoprotein A-II,Physical measures,X46.Hand grip strength (left),44571,-0.023606656249811,0.00345003833838958,-0.0303687313930546,-0.0168445811065675,7.88631541648361e-12
APOA2,Apolipoprotein A-II,Physical measures,X47.Hand grip strength (right),44570,-0.0197038402961719,0.00342566359806605,-0.0264181409483814,-0.0129895396439625,8.88578212805075e-09
APOA2,Apolipoprotein A-II,Physical measures,X48.Waist circumference,44702,-0.0593517990346472,0.00532579951215681,-0.0697903660784746,-0.0489132319908199,8.34133566097204e-29
APOA2,Apolipoprotein A-II,Health and medical history,X4803.Tinnitus,14872,-0.0266738295338999,0.0353679627031206,-0.0959950364320163,0.0426473773642164,0.450752769978233
APOA2,Apolipoprotein A-II,Working and living environment,X4825.Noisy workplace,15073,0.0369136079405665,0.039603379265398,-0.0407090154196135,0.114536231300746,0.351308951178072
APOA2,Apolipoprotein A-II,Working and living environment,X4836.Loud music exposure frequency,14976,-0.0123751829160451,0.0507204118712221,-0.11178719018364,0.0870368243515501,0.807243290580343
APOA2,Apolipoprotein A-II,Physical measures,X49.Hip circumference,44693,-0.0053815158156476,0.00426503017968085,-0.0137409749678221,0.00297794333652687,0.207035726288546
APOA2,Apolipoprotein A-II,Physical measures,X50.Standing height,44654,-0.00730473488736433,0.00338680544893423,-0.0139428735672754,-0.000666596207453234,0.0310248948669843
APOA2,Apolipoprotein A-II,Health and medical history,X5057.Number of older siblings,13326,0.00910471641218345,0.0323851221260083,-0.0543701229547929,0.0725795557791598,0.778608264143057
APOA2,Apolipoprotein A-II,Physical measures,X51.Seated height,44461,-0.0196964585396629,0.0031485412022496,-0.0258675992960721,-0.0135253177832537,3.99227185255038e-10
APOA2,Apolipoprotein A-II,Eye measures,X5181.Ever had eye surgery,10250,0.0680423278137719,0.0731765559368098,-0.0753837218223754,0.211468377449919,0.352477003144027
APOA2,Apolipoprotein A-II,Eye measures,X5186.Duration visual-acuity screen displayed (right),10227,0.00810573804556509,0.00509035503468946,-0.00187135782242624,0.0180828339135564,0.111332125734443
APOA2,Apolipoprotein A-II,Eye measures,X5188.Duration visual-acuity screen displayed (left),10224,0.0116051283213871,0.00515528704963789,0.00150076570409685,0.0217094909386774,0.0243996269807854
APOA2,Apolipoprotein A-II,Eye measures,X5190.Duration at which refractometer first shown (right),10111,0.0124313440082536,0.00517801692224143,0.00228243084066045,0.0225802571758468,0.0163775890094782
APOA2,Apolipoprotein A-II,Eye measures,X5193.Duration at which refractometer first shown (left),10107,0.016731908544815,0.00521624128679122,0.0065080756227042,0.0269557414669258,0.00134239075341572
APOA2,Apolipoprotein A-II,Eye measures,"X5199.logMAR, initial (right)",10188,0.0700531991485671,0.037934534837751,-0.00429848913342494,0.144404887430559,0.0648215920072366
APOA2,Apolipoprotein A-II,Eye measures,X5200.Final number of letters displayed (right),10188,-0.291852623274832,0.248210557768871,-0.778345316501818,0.194640069952155,0.239691617659354
APOA2,Apolipoprotein A-II,Eye measures,"X5201.logMAR, final (right)",10088,0.0115704257877305,0.0051718162542913,0.00143366592931956,0.0217071856461414,0.0252945682793816
APOA2,Apolipoprotein A-II,Eye measures,X5202.Number of rounds to result (right),10188,0.0310571842603981,0.0357736564223818,-0.0390591823274702,0.101173550848266,0.385328369224734
APOA2,Apolipoprotein A-II,Eye measures,"X5206.logMAR, initial (left)",10182,0.0635190772296006,0.0378748607671948,-0.0107156498741012,0.137753804333302,0.0935580663443684
APOA2,Apolipoprotein A-II,Eye measures,X5207.Final number of letters displayed (left),10182,-0.486282558184258,0.220834658706498,-0.919118489248994,-0.0534466271195214,0.0276861985661893
APOA2,Apolipoprotein A-II,Eye measures,"X5208.logMAR, final (left)",10089,0.012875703826755,0.00516408963098133,0.00275408815003158,0.0229973195034784,0.0126715593067454
APOA2,Apolipoprotein A-II,Eye measures,X5209.Number of rounds to result (left),10176,-0.011555001530354,0.035876969265161,-0.0818738612900696,0.0587638582293615,0.747404058041348
APOA2,Apolipoprotein A-II,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",9756,-0.00729760075020862,0.00510190197491593,-0.0172973286210438,0.00270212712062659,0.152643306406112
APOA2,Apolipoprotein A-II,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",9756,-0.00694542926160101,0.00507983961470072,-0.0169019149064144,0.0030110563832124,0.171577358643725
APOA2,Apolipoprotein A-II,Eye measures,X5256.Corneal hysteresis (right),9756,0.00188529695286553,0.00512766171403074,-0.00816492000663472,0.0119355139123658,0.713125907923864
APOA2,Apolipoprotein A-II,Eye measures,X5257.Corneal resistance factor (right),9756,-0.00267119982865669,0.00509482469552738,-0.0126570562318904,0.00731465657457698,0.600084112872715
APOA2,Apolipoprotein A-II,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",9725,-0.0121029161928713,0.00513056064696241,-0.0221588150609176,-0.00204701732482498,0.01834468132868
APOA2,Apolipoprotein A-II,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",9725,-0.0100179795712789,0.0050860324582199,-0.0199866031893899,-4.93559531678876e-05,0.0489006560553767
APOA2,Apolipoprotein A-II,Eye measures,X5264.Corneal hysteresis (left),9725,0.00524637374788111,0.00516241171457688,-0.00487195321268958,0.0153647007084518,0.30952895278194
APOA2,Apolipoprotein A-II,Eye measures,X5265.Corneal resistance factor (left),9725,8.94202325061871e-06,0.00511627324071937,-0.0100189535285593,0.0100368375750606,0.998605525027247
APOA2,Apolipoprotein A-II,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,10127,0.0310826025379819,0.172372272204251,-0.306767050982351,0.368932256058314,0.856902990342771
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",44577,0.0391883281237418,0.0137062504034315,0.012324077333016,0.0660525789144676,0.00424964968307967
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",44577,0.0690865263472871,0.0149328047899782,0.0398182289589298,0.0983548237356443,3.72953125583162e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",44577,0.0617152155222523,0.0143024209807024,0.0336824704000757,0.0897479606444289,1.59932694916754e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",44577,0.0105011963568932,0.0061128421541432,-0.00147997426522751,0.0224823669790138,0.0858234505253314
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",44577,-0.0222256332162212,0.00562824492411189,-0.0332569932674805,-0.0111942731649618,7.86167748305785e-05
APOA2,Apolipoprotein A-II,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",20124,-0.0254147074096672,0.00726013452956861,-0.0396445710876217,-0.0111848437317127,0.00046524606045109
APOA2,Apolipoprotein A-II,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",20124,0.0294310647939303,0.0195176499950433,-0.00882352919635462,0.0676856587842153,0.131590580698799
APOA2,Apolipoprotein A-II,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",20124,-0.0106695322737203,0.0141266976073639,-0.0383578595841536,0.017018795036713,0.450093234510233
APOA2,Apolipoprotein A-II,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",20124,0.00948325539817349,0.00860227949557374,-0.00737721241315105,0.026343723209498,0.270295827438817
APOA2,Apolipoprotein A-II,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,44706,0.000211731440041387,0.00939245304072153,-0.0181974765197728,0.0186209393998556,0.982015135566942
APOA2,Apolipoprotein A-II,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,44706,0.0144610430438483,0.0120047456754187,-0.00906825847997224,0.0379903445676689,0.228360068977032
APOA2,Apolipoprotein A-II,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),44706,-0.00590683824515562,0.0092928990894773,-0.0241209204605311,0.0123072439702199,0.525021371039594
APOA2,Apolipoprotein A-II,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',44706,-0.0156063225601414,0.015172027254896,-0.0453434959797375,0.0141308508594547,0.303661615497499
APOA2,Apolipoprotein A-II,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),44706,0.028970658621033,0.0377984090486341,-0.0451142231142899,0.103055540356356,0.443411569884018
APOA2,Apolipoprotein A-II,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),44706,0.0627212756499963,0.0259302187897028,0.0118980468221789,0.113544504477814,0.0155736829539156
APOA2,Apolipoprotein A-II,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,44706,0.0327021590499862,0.0401400173079054,-0.0459722748735084,0.111376592973481,0.415247154284524
APOA2,Apolipoprotein A-II,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,44576,0.00810591245230203,0.00783231463259296,-0.00724542422758016,0.0234572491321842,0.300706320660826
APOA2,Apolipoprotein A-II,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,44576,0.0130027887909495,0.0133424426305584,-0.0131483987649449,0.0391539763468439,0.329792113953111
APOA2,Apolipoprotein A-II,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,44576,-0.0151788493104828,0.00702016935430831,-0.0289383812449271,-0.00141931737603856,0.0306098332852614
APOA2,Apolipoprotein A-II,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,44576,-0.0017071380309131,0.0116858667856014,-0.0246114369306918,0.0211971608688656,0.88385439573977
APOA2,Apolipoprotein A-II,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,44576,0.00688592980123246,0.0116689420398964,-0.0159851965969645,0.0297570561994294,0.555121596919599
APOA2,Apolipoprotein A-II,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,44576,0.026191652133412,0.0065550840733731,0.0133436873496007,0.0390396169172233,6.46276800602702e-05
APOA2,Apolipoprotein A-II,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,13804,0.0757250386820785,0.0169056258197749,0.0425900120753197,0.108860065288837,7.54970386964837e-06
APOA2,Apolipoprotein A-II,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,13804,0.0567029715492652,0.0145646269572327,0.028156302713089,0.0852496403854413,9.93974910786023e-05
APOA2,Apolipoprotein A-II,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,13804,0.0993067436732453,0.0199397675958434,0.0602247991853922,0.138388688161098,6.42418335792314e-07
APOA2,Apolipoprotein A-II,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,13804,-0.0213731347010628,0.0158526416242434,-0.0524443122845798,0.00969804288245427,0.177603972752054
APOA2,Apolipoprotein A-II,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,44521,0.00607599864540634,0.0197987739683891,-0.0327295983326364,0.0448815956234491,0.758930347317108
APOA2,Apolipoprotein A-II,Health and medical history,X6151#2.Fractured bone site(s)_Leg,44521,0.0602107269883969,0.0297854361310012,0.0018312721716346,0.118590181805159,0.0432358529125957
APOA2,Apolipoprotein A-II,Health and medical history,X6151#3.Fractured bone site(s)_Hip,44521,0.00264315905166139,0.0519593708544566,-0.0991972078230735,0.104483525926396,0.959429556269348
APOA2,Apolipoprotein A-II,Health and medical history,X6151#4.Fractured bone site(s)_Spine,44521,0.14817094733223,0.0493507570991509,0.0514434634178944,0.244898431246566,0.00268004430130475
APOA2,Apolipoprotein A-II,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,44521,0.0330577863778357,0.0172559860711745,-0.000763946321666389,0.0668795190773378,0.0554060474612879
APOA2,Apolipoprotein A-II,Health and medical history,X6151#6.Fractured bone site(s)_Arm,44521,0.0117296553796641,0.0230371967506454,-0.0334232502516009,0.0568825610109291,0.610641498496756
APOA2,Apolipoprotein A-II,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,44521,0.0122348170104549,0.0106312031892498,-0.00860234124047462,0.0330719752613844,0.249804126993435
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",14454,0.0503374692550013,0.0171430706149796,0.0167370508496413,0.0839378876603613,0.00332659988120245
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",14454,0.0307700215926455,0.0182493345309378,-0.00499867408799266,0.0665387172732837,0.0918000572987007
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",14454,0.108064516749561,0.0249101716925375,0.0592405802321879,0.156888453266935,1.44650503469559e-05
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",14454,0.0204455532413956,0.00879023739121745,0.00321668795460941,0.0376744185281818,0.0200355953619763
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",20228,0.036318087667272,0.00838245052957977,0.0198884846292957,0.0527476907052483,1.48046658076178e-05
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",20228,-0.0341614786999237,0.00815775870510128,-0.0501506857619222,-0.0181722716379252,2.831063902436e-05
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",20228,-0.000263998640391391,0.00747743375488426,-0.0149197687999645,0.0143917715191818,0.971836048778435
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",20229,0.0237652655295437,0.0176385841802137,-0.0108063594636753,0.0583368905227626,0.177884112983648
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",20229,0.0292046238050012,0.0105599333899558,0.00850715436068785,0.0499020932493145,0.00568685357254153
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",20229,0.0495558484581281,0.0143417537320175,0.0214460111433737,0.0776656857728825,0.00055069688975612
APOA2,Apolipoprotein A-II,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,44576,0.0137048125406667,0.0164179566694237,-0.0184743825314038,0.0458840076127372,0.403865592120943
APOA2,Apolipoprotein A-II,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,44576,0.0150810029954396,0.0114627145704753,-0.00738591756269195,0.0375479235535712,0.188295893082425
APOA2,Apolipoprotein A-II,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,44576,0.00892341252648966,0.033096964044545,-0.0559466370008184,0.0737934620537978,0.787458298894771
APOA2,Apolipoprotein A-II,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,44576,0.0211009369560358,0.011799922491302,-0.00202691112691614,0.0442287850389876,0.0737462250453133
APOA2,Apolipoprotein A-II,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,44576,0.00463054148983299,0.0134108425363886,-0.0216547098814887,0.0309157928611547,0.729882944590919
APOA2,Apolipoprotein A-II,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),44576,0.0335360940998022,0.0154823503054095,0.00319068750119968,0.0638815006984047,0.0303099407065137
APOA2,Apolipoprotein A-II,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,44576,-0.00350155916644416,0.00510170468976655,-0.0135009003583866,0.00649778202549828,0.492495484126616
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,8719,0.0850473800362078,0.0152456638987981,0.0551658787945635,0.114928881277852,2.4991900578688e-08
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,8719,0.0414430086340824,0.0191753929514872,0.00385923844916748,0.0790267788189973,0.0307024438701493
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,8719,-0.0664437226717559,0.013585131509099,-0.0930705804295899,-0.0398168649139218,1.02166204908625e-06
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,8719,-0.00763017213843807,0.0121912416592701,-0.0315250057906075,0.0162646615137314,0.531414484959669
APOA2,Apolipoprotein A-II,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,44771,-0.00536196092717801,0.00596740548514639,-0.0170580756780649,0.00633415382370892,0.368901813467244
APOA2,Apolipoprotein A-II,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,44771,0.0471111130940762,0.017244864117074,0.0133111794246112,0.0809110467635412,0.00629963896975522
APOA2,Apolipoprotein A-II,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,44771,0.000687576285972489,0.00558837100470582,-0.0102656308832509,0.0116407834551959,0.902078367853804
APOA2,Apolipoprotein A-II,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,44771,0.0219574578896257,0.005407779481946,0.0113582101050115,0.0325567056742398,4.90832518038329e-05
APOA2,Apolipoprotein A-II,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,44771,0.0179000544478075,0.00837909495182501,0.00147702834223052,0.0343230805533846,0.0326623807703184
APOA2,Apolipoprotein A-II,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,44771,0.0107764465076588,0.007441402397526,-0.00380870219149216,0.0253615952068098,0.147575360239514
APOA2,Apolipoprotein A-II,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,44771,0.0164274473943661,0.00581175458258742,0.00503640841249478,0.0278184863762375,0.00470673732603296
APOA2,Apolipoprotein A-II,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,44771,0.0587390819625854,0.0170524969515544,0.0253161879375388,0.0921619759876319,0.000572422545108211
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,31002,0.0151149279320909,0.00588098792863142,0.00358819159197332,0.0266416642722085,0.0101705422865193
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,31002,0.0216096877056059,0.00614076156692604,0.0095737950344309,0.033645580376781,0.000433704822320108
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,31002,-0.0160201512075079,0.00691975185357079,-0.0295828648405066,-0.00245743757450915,0.0206121114501284
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,31003,-0.0146385847391384,0.00944694910660916,-0.0331546049880924,0.00387743550981553,0.121258127317982
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,31003,-0.00782152000110575,0.00621366155834441,-0.0200002966554608,0.00435725665324929,0.208125853086779
APOA2,Apolipoprotein A-II,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,44373,-0.0261928502468479,0.00600303525345138,-0.0379587993436126,-0.0144269011500832,1.28422925459821e-05
APOA2,Apolipoprotein A-II,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,44373,0.000158701811570873,0.00479347246115044,-0.009236504212284,0.00955390783542574,0.973588691097274
APOA2,Apolipoprotein A-II,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,44373,0.0080021003045535,0.00531345243175112,-0.0024122664616787,0.0184164670707857,0.132072316128942
APOA2,Apolipoprotein A-II,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,44373,0.0301605433507833,0.00963012616714557,0.011285496063178,0.0490355906383887,0.00173794896903819
APOA2,Apolipoprotein A-II,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),44403,-0.0186779515170775,0.00528831621818397,-0.0290430513047181,-0.00831285172943689,0.000412960119957672
APOA2,Apolipoprotein A-II,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,44403,0.0320793740875306,0.00828675826578259,0.0158373278865967,0.0483214202884645,0.000108473261257076
APOA2,Apolipoprotein A-II,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),44576,-0.000255912445234303,0.00521520296033692,-0.0104777102474947,0.00996588535702607,0.960863358807487
APOA2,Apolipoprotein A-II,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,44576,-0.00608723606287848,0.00617124246297585,-0.0181828712903112,0.00600839916455419,0.32394838098151
APOA2,Apolipoprotein A-II,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,44576,0.0254032236309843,0.00926539652117444,0.00724304644948237,0.0435634008124862,0.006114077058998
APOA2,Apolipoprotein A-II,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,44576,-0.00199217673795418,0.0119092368236,-0.0253342809122102,0.0213499274363018,0.867150525422312
APOA2,Apolipoprotein A-II,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,44576,0.0424669324169352,0.0128720553791817,0.0172377038737392,0.0676961609601313,0.000970516466709771
APOA2,Apolipoprotein A-II,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,44576,-0.0133993459042646,0.0153757763426323,-0.0435358675358238,0.0167371757272946,0.383508731287121
APOA2,Apolipoprotein A-II,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",25207,-0.0129839502969788,0.00328921145597107,-0.0194308047506821,-0.00653709584327549,7.92072193198376e-05
APOA2,Apolipoprotein A-II,Physical activities,X864.Number of days or week walked 10+ minutes,43811,0.0397027360203508,0.0177182701699544,0.00497492648724023,0.0744305455534614,0.025045355389383
APOA2,Apolipoprotein A-II,Physical activities,X874.Duration of walks,37938,0.00535384234398978,0.00255138431359602,0.000353129089341577,0.010354555598638,0.0358758170490048
APOA2,Apolipoprotein A-II,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,42334,0.0649519038901071,0.0171998230333291,0.0312402507447819,0.0986635570354322,0.000159384950760988
APOA2,Apolipoprotein A-II,Physical activities,X894.Duration of moderate activity,32782,0.0169439693703127,0.0209050067539449,-0.0240298438674194,0.0579177826080447,0.417646071741026
APOA2,Apolipoprotein A-II,Physical activities,X90087.No-wear time bias adjusted average acceleration,9165,0.000727012222701237,0.00542241420250951,-0.00990091961421741,0.0113549440596199,0.893345919385171
APOA2,Apolipoprotein A-II,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,42292,0.0796987352331935,0.0176969703016231,0.0450126734420121,0.114384797024375,6.70142602647702e-06
APOA2,Apolipoprotein A-II,Physical activities,X914.Duration of vigorous activity,23653,0.00881466128691385,0.00318032241082323,0.00258122936170032,0.0150480932121274,0.00558208512388257
